{"count":60,"next":"https://lda.gov/api/v1/filings/?filing_specific_lobbying_issues=S.+2903&filing_year=2026&ordering=-filing_year&page=2","previous":null,"results":[{"url":"https://lda.gov/api/v1/filings/0ae176b8-7c46-4df3-a83c-c62daa9948ff/","filing_uuid":"0ae176b8-7c46-4df3-a83c-c62daa9948ff","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/0ae176b8-7c46-4df3-a83c-c62daa9948ff/print/","filing_document_content_type":"text/html","income":null,"expenses":"40000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Erin McKeon","dt_posted":"2026-04-14T14:42:51-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"733 Third Ave","registrant_address_2":"Suite 510","registrant_different_address":false,"registrant_city":"New York","registrant_state":"NY","registrant_zip":"10017","registrant":{"id":401105490,"url":"https://lda.gov/api/v1/registrants/401105490/","house_registrant_id":55808,"name":"CROHN'S & COLITIS FOUNDATION","description":null,"address_1":"733 Third Ave","address_2":"Suite 510","address_3":null,"address_4":null,"city":"New York","state":"NY","state_display":"New York","zip":"10017","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ERIN MCKEON","contact_telephone":"+1 202-210-1632","dt_updated":"2026-08-28T16:41:16.576715-04:00"},"client":{"id":55519,"url":"https://lda.gov/api/v1/clients/55519/","client_id":55519,"name":"CROHN'S & COLITIS FOUNDATION","general_description":"Nonprofit patient foundation.","client_government_entity":null,"client_self_select":true,"state":"NY","state_display":"New York","country":"US","country_display":"United States of America","ppb_state":"NY","ppb_state_display":"New York","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2023-01-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"FY 2026 Funding for medical research at the NIH and CDC FY 2026 Appropriations - DoD Congressionally Directed Medical Research Program Help Ensure Lower Patient Copays Act Accelerating Kids Access to Care Act Pharmacy Benefit Manager Transparency Act Reauthorization of ACA enhanced advance premium tax credits HR 5509 / S 2903: Safe Step Act CMS - ACA Marketplace Integrity and Affordability Rule CMS - Reimbursement for infused biosimilars CMS - Medicare Competitive bidding for ostomy supplies FDA - Approvals for pediatric IBD medications HHS - FY 2027 NBPP","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152894,"prefix":"ms","prefix_display":"MS.","first_name":"ERIN","nickname":null,"middle_name":"HENNESSEY","last_name":"MCKEON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/3fd8b296-e504-4946-9d39-fde5ba084aa0/","filing_uuid":"3fd8b296-e504-4946-9d39-fde5ba084aa0","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/3fd8b296-e504-4946-9d39-fde5ba084aa0/print/","filing_document_content_type":"text/html","income":null,"expenses":"210000.00","expenses_method":"B","expenses_method_display":"B","posted_by_name":"8r1","dt_posted":"2026-04-15T11:09:05-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"2318 Mill Rd","registrant_address_2":"Suite 800","registrant_different_address":false,"registrant_city":"Alexandria","registrant_state":"VA","registrant_zip":"22314","registrant":{"id":401105592,"url":"https://lda.gov/api/v1/registrants/401105592/","house_registrant_id":null,"name":"ASSOCIATION FOR CLINICAL ONCOLOGY","description":"physician medical specialty society","address_1":"2318 Mill Rd","address_2":"Suite 800","address_3":null,"address_4":null,"city":"Alexandria","state":"VA","state_display":"Virginia","zip":"22314","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ANTHONY PEREZ","contact_telephone":"+1 571-483-1496","dt_updated":"2026-07-21T14:12:19.395401-04:00"},"client":{"id":205751,"url":"https://lda.gov/api/v1/clients/205751/","client_id":12,"name":"ASSOCIATION FOR CLINICAL ONCOLOGY","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"VA","state_display":"Virginia","country":"US","country_display":"United States of America","ppb_state":"VA","ppb_state_display":"Virginia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2020-01-01"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"H.R. 3514/S. 1816: Improving Seniors' Timely Access to Care Act of 2025 - requires Medicare Advantage plans to implement electronic prior authorization, increase transparency, protect enrollees, and adhere to new response timeframes to improve timely access to care. S. 1640/H.R. 879: Medicare Patient Access and Practice Stabilization Act of 2025 - This bill increases certain payment adjustments under the Medicare physician fee schedule for services furnished between April 1, 2025, and January 1, 2026. S. 1460/H.R. 786: Preserving Patient Access to Accountable Care Act - extends Medicare incentive payments for alternative payment models to 2027, with a new rate of 3.53 percent, to promote continued participation and improve healthcare efficiency. H.R. 4206/S. 1261: CONNECT for Health Act - expands access to telehealth services under Medicare H.R. 2433: Reducing Medically Unnecessary Delays in Care Act - mandates that prior authorization decisions under Medicare be made by qualified physicians, based on medical necessity and evidence-based standards, with transparency and input from practicing physicians. H.R. 1509/S. 752: Accelerating Kids Access to Care Act - To amend titles XIX and XXI of the Social Security Act to streamline the enrollment process for eligible out-of-state providers under Medicaid and CHIP. H.R. 2484: Seniors' Access to Critical Medications Act of 2025 - establishes an exception to the physician self-referral prohibition for certain outpatient drugs under Medicare, mandates a study on drug dispensing practices, and reduces the Medicare improvement fund by $18 million. H.R. 2120/S. 1031: ROCR Value Based Program Act - establishes a new payment program for radiation oncology services, focusing on stable payments, quality care, and patient access, while exempting it from budget neutrality adjustments. H.R. 4559: Prompt and Fair Pay Act - to establish payment parity between Medicare Advantage and fee-for-service Medicare, and to establish prompt payment requirements under Medicare Advantage. H.R. 4299: Protecting Patient Access to Cancer and Complex Therapies Act - provide for a rebate by manufacturers for selected drugs and biological products subject to maximum fair price negotiation. H.R. 5081/S. 2709: Telehealth Modernization Act - to extend certain telehealth flexibilities under the Medicare program. H.R. 4752/S. 2760: Reducing Hereditary Cancer Act - to provide hereditary cancer genetic testing for individuals with a history of a hereditary cancer gene mutation.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":120202,"prefix":null,"prefix_display":null,"first_name":"KRISTINE","nickname":null,"middle_name":null,"last_name":"RUFENER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141122,"prefix":null,"prefix_display":null,"first_name":"KATIE","nickname":null,"middle_name":null,"last_name":"GIFFORD","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"H.R. 6423/S. 864: HELP Copays Act - requires health insurers to count third-party financial assistance toward patients' cost-sharing obligations, including deductibles and copays, for prescription drugs, with changes effective for plan years beginning January 1, 2026. S. 526: PBM Transparency Act - prevents unfair and deceptive acts or practices and the dissemination of false information related to pharmacy benefit management services for prescription drugs H.R. 1262/S. 932: Mikaela Naylon Give Kids a Chance Act of 2025 - To amend the Federal Food, Drug, and Cosmetic Act with respect to molecularly targeted pediatric cancer investigations, and for other purposes. HR 929/S.266: Dr. Lorna Breen Health Care Provider Protection Reauthorization Act - To reauthorize the Dr. Lorna Breen Health Care Provider Protection Act, and for other purposes. H.R. 4191/S. 1784: MAPS Act - requires federal agencies to regularly update a list of essential medicines, assess and report on supply chain risks, map pharmaceutical supply chains, and enhance coordination and cybersecurity to protect public health and national security. H.R. 3955/S.2062: RAPID Reserve Act - establishes a $500 million program to create and maintain domestic reserves of critical drugs and their ingredients, prioritizing domestic manufacturing and supply chain resilience to prevent shortages during public health emergencies. S. 1954: Biosimilar Red Tape Elimination Act - streamlines the approval process for biosimilar biological products by automatically deeming them interchangeable with reference products, subject to certain exclusivity protections, and requires updated regulatory guidance to reflect these changes. H.R. 4101: Cancer Drug Parity Act of 2025 - requires group health plans to provide cost-sharing for oral anticancer drugs that is at least as favorable as for provider-administered anticancer medications, with protections against increased patient costs and a mandated GAO study on the law's impact. H.R. 3521: Clinical Trials Modernization Act - Increase clinical trial participation among underrepresented populations by providing grants, permitting certain participant reimbursements, and offering tax exclusions, while ensuring compliance with existing legal protections. S. 705: Innovation in Pediatric Drugs Act of 2025 - amends existing laws to enhance pediatric cancer research, mandates compliance measures, allocates funding for pediatric studies, and sets guidelines for orphan drugs, with specific timelines for implementation and evaluation. H.R. 5509/S. 2903: Safe Step Act - to require a group health plan or health insurance coverage offered in connection with such a plan to provide an exceptions process for any medication step therapy protocol, and for other purposes. H.R. 4425/S. 2287: Palliative Care and Hospice Education and Training Act - expands federal support for workforce development, education, public awareness, and research in palliative and hospice care, with targeted funding and statutory changes to improve care for patients with serious or life-threatening illnesses.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":120202,"prefix":null,"prefix_display":null,"first_name":"KRISTINE","nickname":null,"middle_name":null,"last_name":"RUFENER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141122,"prefix":null,"prefix_display":null,"first_name":"KATIE","nickname":null,"middle_name":null,"last_name":"GIFFORD","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"FY 2026 Appropriations for the National Institutes of Health (NIH), National Cancer Institute (NCI), the Food & Drug Administration (FDA), the Advanced Research Projects Agency for Health (ARPA-H), the Centers for Disease Control and Prevention (CDC), and the Department of Defense's Peer Reviewed Cancer Research Program (PRCRP). FY 2027 Appropriations for the National Institutes of Health (NIH), National Cancer Institute (NCI), the Food & Drug Administration (FDA), the Advanced Research Projects Agency for Health (ARPA-H), the Centers for Disease Control and Prevention (CDC), and the Department of Defense's Peer Reviewed Cancer Research Program (PRCRP).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":120202,"prefix":null,"prefix_display":null,"first_name":"KRISTINE","nickname":null,"middle_name":null,"last_name":"RUFENER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141122,"prefix":null,"prefix_display":null,"first_name":"KATIE","nickname":null,"middle_name":null,"last_name":"GIFFORD","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/b93234c1-19a5-4ded-9bb6-d9bd3db04a01/","filing_uuid":"b93234c1-19a5-4ded-9bb6-d9bd3db04a01","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/b93234c1-19a5-4ded-9bb6-d9bd3db04a01/print/","filing_document_content_type":"text/html","income":null,"expenses":"10000.00","expenses_method":"B","expenses_method_display":"B","posted_by_name":"Hannah Wesolowski","dt_posted":"2026-04-16T14:36:37-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"4301 Wilson Blvd.","registrant_address_2":"Suite 300","registrant_different_address":false,"registrant_city":"Arlington","registrant_state":"VA","registrant_zip":"22203","registrant":{"id":26502,"url":"https://lda.gov/api/v1/registrants/26502/","house_registrant_id":32550,"name":"NATIONAL ALLIANCE ON MENTAL ILLNESS","description":null,"address_1":"2107 WILSON BLVD, #300","address_2":null,"address_3":null,"address_4":null,"city":"ARLINGTON","state":"VA","state_display":"Virginia","zip":"22201","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"HANNAH WESOLOWSKI","contact_telephone":"+1 703-516-7962","dt_updated":"2026-07-27T10:01:35.419873-04:00"},"client":{"id":134195,"url":"https://lda.gov/api/v1/clients/134195/","client_id":12,"name":"NATIONAL ALLIANCE ON MENTAL ILLNESS","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"VA","state_display":"Virginia","country":"US","country_display":"United States of America","ppb_state":"VA","ppb_state_display":"Virginia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"1996-02-14"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"H.R.2223: Building Capacity for Care Act: Grans and loan guarantees to build mental health facilities. S.931: Complete Care Act: Integrating Behavioral health care into primary care H.R. 1906:Rural Wellness Act: Grants for telemedicine to provide Access to care in rural communities S. 779/H.R. 1735: EARLY Minds Act allows States to use some Mental Health Block Grant funds towards prevention and early intervention activities. H.R. 1902: HERO Act allows for the collection of data on first responder suicides to better identify and treat PTSD and combat suicide. S. 665: Fatal Overdose Reduction Act of 2025 creates hubs to treat substance use disorders. H.R. 1305: Improving Measurements for Loneliness and Isolation Act of 2025 creates a working group to better understand and define loneliness and isolation. S. 600: Supporting Adopted Children and Families Act enhances pre and post adoption services. S. 454: Gambling Addiction Recovery, Investment, and Treatment Act creates grants for state to address gambling addiction. S. 266/H.R. 929: Dr. Lorna Breen Health Care Provider Protection Reauthorization Act continues education and awareness for mental health services. H.R. 2483: SUPPORT for Patients and Communities Reauthorization Act of 2025 extends and expands grants for serious mental illness and substance use disorder. Support for the inclusion of those with lived experience on the Make America Health Again (MAHA) Commission Support for staffing levels as of 1.1.25 at HHS and SAMHSA Support for Maternal Mental Health programs and funding Support for ending Medicare's 190-day lifetime limit on inpatient psychiatric care -- H.R. 1141: Gambling Addiction Recovery, Investment, and Treatment Act authorizes grants to states and research funding to address gambling addiction. H.R. 2044: Suicide Prevention Assistance Act establishes grants for primary care offices to provide self-harm and suicide prevention services. H.R. 2223: Building Capacity for Care Act provides financial support for developing mental health and substance use disorder treatment facilities. H.R. 2305: Corrections Officer Blake Schwarz Suicide Prevention Act of 2025 establishes a grant program to fund mental health screenings and referrals for corrections officer. H.R. 2587/S.1266: Youth Mental Health Research Act establishes a collaborative research initiative within the NIH to improve youth mental health. H.R. 2630: Youth Suicide Prevention Research Act expands research focus areas on childhood suicide to include adverse childhood experiences and toxic stress. H.R. 2904: Pursuing Equity in Mental Health Act authorizes federal grants for culturally competent research, outreach, provider training, and priority support for programs. H.R. 2936: Addressing Boarding and Crowding in the Emergency Department Act allows grants for tracking hospital bed capacity and introduces pilot programs for emergency care improvements. H.R. 2957: STRONG Support for Children Act of 2025 establishes programs aimed at preventing and mitigating childhood trauma through data analysis and strategy implementation. H.R. 3103: Health Share Transparency Act of 2025 requires health care sharing ministries to disclose financial and operational information to federal agencies and enrollees. H.R. 3130: FACTS Act establishes education and public health partnerships to prevent synthetic opioid misuse among youth. H.R. 3262: NURSE Act creates grants to increase school nurses in under-resourced schools. H.R. 3266: Mental Health Infrastructure Improvement Act of 2025 provides loans to expand and improve pediatric and adult mental health and substance use disorder treatment facilities. H.R. 3420: Words Matter Act of 2025 replacing outdated and stigmatizing terms related to intellectual disabilities with more respectful language. H.R. 3505: Barriers to Suicide Act of 2025 creates a grant program to install nets and barriers on infrastructures like bridges and railroads. H.R. 3520: STAND Against Emerging Opioids Act schedules tianeptine and its analogues as Schedule III controlled substances. H.R. 3601: National ACERT Grant Program Authorization Act establishes a new grant program focused on addressing adverse childhood experiences related to trauma exposure. H.R. 3689: TREAT Youth Act reauthorizes and increases funding for youth substance use prevention and recovery initiatives under the SUPPORT for Patients and Communities Act. H.R. 3743: Supporting Healthy Mothers and Infants Act of 2025 modernizes language for substance use disorder and expands nutrition education and outreach. S. 1056: Home-Based Telemental Health Care Act of 2025 establishes a grant program to improve mental health and substance use services for rural populations through telemental health care. S. 1062: Suicide Prevention Act establishes programs to enhance surveillance of self-harm and provide suicide prevention services in hospital emergency departments. S. 1074: Agricultural Access to Substance Use Disorder Treatment and Mental Health Care Act of 2025 requires a study on the accessibility of mental health and substance use disorder services for farmers and ranchers. S. 1261: CONNECT for Health Act of 2025 seeks to expand telehealth access by removing geographic restrictions. S. 1329/H.R. 2741: PEER Support Act supports and professionalizes peer support specialists and establishes an Office of Recovery. S. 139: FASD Respect Act reauthorize and extend the Fetal Alcohol Spectrum Disorders (FASD) Prevention and Services program. S. 1448: Pursuing Equity in Mental Health Act seeks to improve mental health services and reduce disparities for racial and ethnic minority youth through increased funding, research, and education initiatives. S. 1663/H.R. 3243: Therapeutic Fraud Prevention Act of 2025 prohibits commercial conversion therapy. S. 1673/H.R. 3260: Mental Health Improvement Act extends the authorization period for mental and behavioral health education and training grants. S. 1689/ H.R. 3316: Stop Mental Health Stigma in Our Communities Act of 2025 mandates the development of a national outreach and education strategy tailored to the cultural and linguistic needs of AANHPI populations. S. 1878: ATTAIN Mental Health Act creates an online dashboard to centralize public access to information about federal and state grants for mental health and substance use disorder programs. S. 473: SENIOR Act address loneliness among older adults by requiring screenings, coordinating services, and preparing a report on loneliness. S. 931/H.R. 2509: COMPLETE Care Act incentivizes behavioral health integration with primary care through increased payments and technical assistance. S.Res. 208: A resolution supporting the designation of May 10, 2025, as \"National Asian American, Native Hawaiian, and Pacific Islander Mental Health Day.\" S.Res. 249/H.Res. 441: A resolution expressing support for the designation of May 2025 as \"Mental Health Awareness Month.\" H.R. 3305. Barriers to Suicide Act: Creates a grant program to provide suicide barriers on bridges and other structures H.Res 542/S. 332: Expressing support for the designation of the month of June 2025 as National Post-traumatic stress Awareness Month and June 27, 2025 as National Post-traumatic Stress Awareness Day H.Res 671: Prioritizing Mental Health to the Same Degree as Physical Health to address the epidemics of suicide and drug overdose in the United States H.Res 697/ S. Res 385: Recognizing Suicide as a serious public health problem and supporting September as National Suicide Prevention Month and September 10 as World Suicide Prevention Day H.Res 764: Recognizing the continuing disparities in Black youth mental health and access to care H.R. 4400/S. 2282: Farmers First Act: reauthorizes and expands funding of the Farm Ranch Suicide Prevention Act. HR 4723/ S.2446: Mental Health For Latinos Act: Directs the development of a culturally tailored mental health outreach and education strategy for Hispanic and Latino Populations. S. 2556: Protecting Health Care and Lowering Costs Act: repeals recent health law changes, permanently expands ACA Tax Credits beyond 400% FPL, and sets a new sliding scale for premium contributions H.Res 684: A resolution expressing support for the designation of September 9, 2025, as National Firearms Suicide Prevention Day HR 5509/S 2903: The Safe Step Act: Creates a clear process to appeal step therapy process S.2826/H.R. 5434:The 988 LGBTQ+ Youth Access Act of 2025: Mandates that at least 9% of suicide prevention hotline funding be reserved for specialized services supporting LGBTQ + youth H.R. 1492: To Amend title XI of the Social Security Act to equalize the negotiation period between small molecule and biologic candidates under the Drug Price Negotiation Program H.R. 2085: The Mental Health Research Accelerator Act: establishes programs to speed up mental health research and innovations H.R. 3419: To Amend the Public Health Service Act to reauthorize the telehealth network and telehealth resource center grant program H.R. 4805: WINGS ACT: Requires a report on the long-term brain and mental health effects of military aviation. H.R. 5306: Gun Suicide Prevention Act of 2025: requires all firearms sold in the United States to display the suicide prevention lifeline label H.R. 5733: Community Mental Wellness Worker Training Act: establishes a grant program to train and certify community mental wellness workers H.R. 5859: Behavioral Health Crisis Care Centers Act: establishes a grant program to fund comprehensive, one stop crisis facilities H.R. 5861: Legacy Act of 2025 mandates a study on creating a secure, national system for storing and retrieving last wish documents. H.R. 6226 Latino Youth Mental Health Empowerment Act: Establish a Mental Health awareness campaign focused on Latino youth. H.R. 6817 To establish a home-based telemental health care grant program to increase mental health and substance use services for individuals in fishing, farming and forestry occupations H.Res. 792 Declaring a need for increased investment in youth mental Health and recognizing youth mental health day and youth suicide prevention day. S.2005 IDeA Reauthorization Act: Strengthens the NIH's Institutional Development Award Program S.2131/H.R. 5828 Dad's Matter Act: Requires a federal public awareness campaign and state guidance to promote fatherhood. S.2336: Halting the Epidemic of Addiction and Loss Act: Update grant program regulation and guidance to include all FDA opioid reversal agents, not just Naloxone S. 2825/H.R.5417 Health Access Innovation Act 2025: grant program to support faith and community-based organizations in addressing health inequities and chronic disease. S.3199 988 Lifeline Location Improvement Act: creates an advisory committee to study and recommend a solution for transmitting geolocation information with 988 calls. S. 3076 Nitazene Control Act: permanently classifies all nitazene opioids as schedule 1 Support for improving integrated care for those with Tardive Dyskinesia H.R. 6249: Addressing Addiction After Disasters Act expands federal disaster relief to include SUD and AUD services alongside mental health support. H.R. 6283: FOSTER Act expand opioid response grants and defines and supports kinship caregivers. H.R. 6396: Kid PROOF Act of 2025 expands grant eligibility and funding to support suicide and overdose prevention among youth. H.R. 6630: Expanding Mental Health Access for Cyber Command Personnel Act requires security-cleared behavioral health professionals to be assigned to Cyber Command locations. H.R. 6679: Tech Wellness for Young Men Act requires a study on the mental, social, and developmental impacts of screen addiction among young men. H.R. 6680: Tech Wellness for Men Act study on the economic, mental health, and social impacts of screen addiction among adult men. H.R. 6940: Hope Heals Act of 2026 requires an assessment amount Executive departments to enhance mental health. H.R. 7030: Securing Facilities for Mental Health Services Act expands access to federal mortgage insurance for all licensed hospitals, including mental health facilities. H.R. 7602: State of Men's Health Act requires a study on men's health disparities and establishes an Office of Men's Health. H.R. 8124: STOP Suicide Act creates a grant program to support evidence-based stabilization services for individuals with serious suicidal thoughts. H.R. 8149: Agricultural Access to Addiction and Mental Health Care Act mandates a study on improving access to addiction and mental health care for farmers and ranchers. H.R. 8160: Premenstrual Dysphoric Disorder Awareness and Research Act of 2026 expand research, raise awareness, improve provider education, and increase access to care for PMDD. H.R.8122: 9-8-8 Connect Act allocates $30 million for crisis center follow-up services. S. 3230: Family Caregiver Peer Support Act creates grants to expand in-person and virtual peer support programs for family caregivers. S. 3271: In-Home CARE Act authorizes grants to support family caregivers through home visiting programs. S. 3402: Ensuring Excellence in Mental Health Act expands and standardizes community behavioral health clinic services S. 3431: Improving Measurements for Loneliness and Isolation Act of 2025 establishes a working group to standardize how loneliness and isolation are defined and measured. S. 3461: RISE from Trauma Act authorizes expands and builds trauma-informed systems for youth and families affected by trauma, violence, and substance use. S. 3714: Family-to-Family Reauthorization Act of 2026 extends and specifies funding for family-to-family health information centers. S. 3840/H.R. 7496: Health Investment Zones Act of 2026 creates Health Investment Zones for incentives, grants, and support to reduce health disparities. S. 921: Tyler's Law requires a federal study and subsequent guidance on whether hospital emergency departments should routinely test for fentanyl in overdose cases. H.R. 7875: Providing Opportunities for Individuals in Need of Treatment and Support (POINTS) Act of 2026 expands prevention, treatment, and recovery services for individuals experiencing gambling addiction. S. 4001/H.R. 7828: Supplemental Security Income Restoration Act of 2026 modernizes SSI eligibility and benefit rules.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":139015,"prefix":"ms","prefix_display":"MS.","first_name":"HANNAH","nickname":null,"middle_name":null,"last_name":"WESOLOWSKI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141549,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"MATTHEW","last_name":"LINSKEY","suffix":null,"suffix_display":null},"covered_position":"Legislative Correspondent for Debbie Wassermann Schultz 4/2005-10/2005","new":false},{"lobbyist":{"id":149684,"prefix":null,"prefix_display":null,"first_name":"JOANNA","nickname":null,"middle_name":null,"last_name":"ROSEN","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":53,"name":"Federal Communications Commission (FCC)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":37,"name":"Justice, Dept of (DOJ)"},{"id":9,"name":"President of the U.S."},{"id":1,"name":"SENATE"},{"id":141,"name":"Substance Abuse & Mental Health Services Administration (SAMHSA)"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Appropriations requests for Commerce, Justice, Science, and Related Agencies for FY 2027 Appropriations requests for Department of Housing and Urban Development - funding for Housing programs for those with SUD and/or SMI for FY 2027 Appropriations requests for Department of Labor, Health and Human Services, and Education and Related Agencies for FY 2027","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":139015,"prefix":"ms","prefix_display":"MS.","first_name":"HANNAH","nickname":null,"middle_name":null,"last_name":"WESOLOWSKI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141549,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"MATTHEW","last_name":"LINSKEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149684,"prefix":null,"prefix_display":null,"first_name":"JOANNA","nickname":null,"middle_name":null,"last_name":"ROSEN","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":157,"name":"Bureau of Justice Assistance"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":35,"name":"Housing & Urban Development, Dept of (HUD)"},{"id":37,"name":"Justice, Dept of (DOJ)"},{"id":243,"name":"Natl Institute of Mental Health (NIMH)"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":9,"name":"President of the U.S."},{"id":1,"name":"SENATE"},{"id":141,"name":"Substance Abuse & Mental Health Services Administration (SAMHSA)"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"TEC","general_issue_code_display":"Telecommunications","description":"H.R. 912: 9-8-8 Lifeline Cybersecurity Responsibility Act strengthens the cybersecurity protocols for the Lifeline. S. 414: ADS for Mental Health Services Act requires social media sites to report their public service ads. Ensuring the proper routing of 988 lifeline calls, texts, and chats -- H.R. 3757: Pride In Mental Health Act of 2025 establishes a grant program to enhance mental health services, protections, and data collection for LGBTQ+ youth. S. 1007: 9-8-8 Lifeline Cybersecurity Responsibility Act mandating rapid reporting of vulnerabilities and incidents. S. 1611: Youth Substance Use Prevention and Awareness Act promotes youth substance use prevention through expanded public service announcement campaigns. S. 1797: Expanding Seniors Access to Mental Health Services Act: Expands Medicare coverage and reimbursement for clinical social worker mental health services H.R. 5045: Health AI Act establishes a grant program to fund research on generative AI in health care. S. 1748: Kids Online Safety Act: requires online platforms used by minors to implement safety, privacy, and parental controls. S. 3199: 988 Lifeline Location Improvement Act creates an advisory committee to study and recommend solutions for transmitting geolocation information with 988.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141549,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"MATTHEW","last_name":"LINSKEY","suffix":null,"suffix_display":null},"covered_position":"Legislative Correspondent Debbie Wasserman Schultz 4/2005-10/2005","new":false},{"lobbyist":{"id":139015,"prefix":"ms","prefix_display":"MS.","first_name":"HANNAH","nickname":null,"middle_name":null,"last_name":"WESOLOWSKI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149684,"prefix":null,"prefix_display":null,"first_name":"JOANNA","nickname":null,"middle_name":null,"last_name":"ROSEN","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":53,"name":"Federal Communications Commission (FCC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"H.R. 169: Prevent Family Fire Act provides a tax credit for retailers to incentivize the sale of safe storage devices for firearms. S. 46/H.R. 247: Health Care Affordability Act of 2025 expands access to tax credits by eliminating income caps and adjusting premium percentages. -- S. 1676/ HR 3308: RETAIN Act introduces a refundable tax credit to retain educators and school leaders in high-need areas S. 925/H.R. 2036: Credit for Caring Act of 2025 creates a tax credit for working family caregivers. H.R. 1582: Volunteer Driver Tax Appreciation Act of 2025: increase the charitable mileage rate to match the business travel for certain charitable activities. HR 5145: Bipartisan Premium Tax Credit Extension Act, extends enhances premium tax credits and expanded eligibility for health insurance subsides through 2026","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141549,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"MATTHEW","last_name":"LINSKEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139015,"prefix":"ms","prefix_display":"MS.","first_name":"HANNAH","nickname":null,"middle_name":null,"last_name":"WESOLOWSKI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149684,"prefix":null,"prefix_display":null,"first_name":"JOANNA","nickname":null,"middle_name":null,"last_name":"ROSEN","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"LAW","general_issue_code_display":"Law Enforcement/Crime/Criminal Justice","description":"H.R. 1510/S.1720: Due Process Continuity of Care Act extends Medicaid to those in custody pending charges H.R. 1392: Improving Mental Healthcare in the Re-Entry System Act of 2025 creates grants for mental health screenings and referrals. Support for expanding reentry services for those leaving or about to leave incarceration, including the use of 1115 waivers -- H.R. 2502: Law Enforcement Training for Mental Health Crisis Response Act of 2025 funds behavioral health crisis response training for law enforcement and corrections officers. H.R. 2586: Reentry Act of 2025 allows Medicaid coverage for inmates 30 days before their release. H.R. 2879: Prison Staffing Reform Act of 2025 requires a comprehensive review and strategic plan to address understaffing in the Bureau of Prisons. H.R. 3312: SERVICE Act of 2025 establishes a pilot program to create veterans response teams within law enforcement agencies. H.R. 3372: Law Enforcement Scenario-Based Training for Safety and De-Escalation Act of 2025 establishes a scenario-based training curriculum for law enforcement. H.R. 3621: Public Safety and Mental Health Reporting Act mandates annual federal data collection and public reporting on law enforcement interactions with people with mental illness. H.R. 3658: 911 Community Crisis Responders Act of 2025 establishes a federal grant program to support unarmed, community-based crisis response teams for nonviolent 911 calls. S. 1843: Second Chance Reauthorization Act of 2025 reauthorizes and expands funding for reentry, substance abuse treatment, education, and support programs for formerly incarcerated individuals. S. 1897: A bill to amend the Omnibus Crime Control and Safe Streets Act of 1968 to establish the Adverse Childhood Experiences Response Team grant program, and for other purposes. S. 768: Invest to Protect Act of 2025 establishes a grant program to support local law enforcement agencies with training, mental health resources, and recruitment. S. 825: Fighting Post-Traumatic Stress Disorder Act of 2025 creates a program for providing PTSD treatment to public safety officers. S. 2248: Juvenile Justice and Delinquency Prevention Reauthorization Act reauthorize key delinquency prevention programs and bolster federal protections for incarcerated minors. H.R. 4024: Filling Public Safety Vacancies Act provides a boost to the federal grant program that provides funding to departments for recruitment and hiring. S.2532 Safe Response Act expands and updates first responder training programs H.R. 5725: Mental Health Crisis Response Act establishes a grant program to help implement health centered alternation to law enforcement for mental health emergencies H.R. 6002 Supporting Blue Envelope Program Act: Establish a grant program to support Blue Envelope programs for Autism Awareness S.2532 Safe Response Act expands and updates first responder training programs to address a wider range of drug related emergencies and increases funding. H.R. 6548: DHS Suicide Prevention and Resiliency for Law Enforcement Act creates a mental health and suicide prevention program for DHS law enforcement personnel. H.R. 7309: Reentry Resource Guide Act of 2026 creates a pilot program to help states develop digital guides connecting formerly incarcerated individuals with essential reentry resources. H.R. 7447: Community Risk Training and Response Act of 2026 establishes a grants for risk protection orders and crisis intervention programs.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141549,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"MATTHEW","last_name":"LINSKEY","suffix":null,"suffix_display":null},"covered_position":"Legislative Correspondent for Debbie Wassermann Schultz 4/2005-10/2005","new":false},{"lobbyist":{"id":139015,"prefix":"ms","prefix_display":"MS.","first_name":"HANNAH","nickname":null,"middle_name":null,"last_name":"WESOLOWSKI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149684,"prefix":null,"prefix_display":null,"first_name":"JOANNA","nickname":null,"middle_name":null,"last_name":"ROSEN","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":157,"name":"Bureau of Justice Assistance"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":37,"name":"Justice, Dept of (DOJ)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"EDU","general_issue_code_display":"Education","description":"H.R. 1448: PEER Mental Health Act of 2025 authorizes grants for peer mental health first aid training in schools, with a focus on rural areas. S. 906: Peer to Peer Mental Health Support Act creates a pilot program for mental health peer support activities in schools. H.R. 1649: Expanding Student Access to Mental Health Services Act enhances student mental health and telehealth services. -- H.R. 3567: Put School Counselors Where Theyre Needed Act creates a federally funded demonstration project to provide additional school counselors in low-graduation-rate Title I secondary schools. H.R. 3655: STAR Plus Scholarship Act creates a federally funded scholarship program to increase and diversify the behavioral and mental health workforce in shortage areas. S. 1895/H.R. 3534: Mental Health in Schools Excellence Program Act of 2025 creates a federal matching grant program to help graduate students afford degrees in school-based mental health fields. S. 1924/H.R. 3624: Improving Mental Health Access for Students Act requires colleges and universities to provide suicide prevention contact information on student ID cards. H.R. 3939: Respond, Innovate, Support, and Empower (RISE) Act allows college students to use previous documentation as proof of disability when seeking accommodations in their courses. H.R. 4120: Supporting the Mental Health of Educators and Staff Act establishes funding, programs, and reporting requirements to improve mental health and resiliency among education professionals and school staff. H.R. 5557: Mental Health Services for Students Act of 2025: enhances and extends school-based mental health services for students. H.R. 4186: Connecting Students with Mental Health Services Act: Establishes a grant program to expand telehealth services for school children H.R. 5357: College Students Continuation of Mental Health Care Act: Allows College Mental Health providers to offer services across state lines H.R. 5482: Prevent Youth Suicide Act: Evidence-based suicide prevention programs for students H.R. 5553: CTE Student Mental Health and Wellness Act: expands eligibility for federal mental health and substance use disorder grants H.R. 6133: Increasing Access to Mental Health in Schools Act: Establishes a grant and loan repayment program for school-based mental health providers H.R. 6672: Mental Health Professionals Workforce Shortage Act: Creates a federal loan repayment program for certain mental health professionals S942/H.R. 2028: Redi Act: Interest free deferment on student loans for borrowers in medical or dental internships or residency programs H.R. 7019: Campus Prevention and Recovery Services for Students Act of 2026 expands campus alcohol and substance misuse prevention programs. H.R. 7497: Supporting Trauma-Informed Education Practices Act of 2026 expand evidence-based trauma support and mental health services for children and youth in schools. H.R. 7787: Mental Health Workforce Act creates a loan deferment and forgiveness program for mental health professionals. S. 3448/H.R. 6617: Keeping All Students Safe Act prohibits seclusion and restricts the use of restraint in federally funded educational settings. S. 4061/H.R. 7092: RAYS Act requires K-12 schools to provide mental health and suicide prevention contact information on student IDs. S. 3783/H.R. 7394: Mental Health Career Promotion Act establishes a grant program to promote mental and behavioral health careers.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141549,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"MATTHEW","last_name":"LINSKEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139015,"prefix":"ms","prefix_display":"MS.","first_name":"HANNAH","nickname":null,"middle_name":null,"last_name":"WESOLOWSKI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149684,"prefix":null,"prefix_display":null,"first_name":"JOANNA","nickname":null,"middle_name":null,"last_name":"ROSEN","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":32,"name":"Education, Dept of"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"INS","general_issue_code_display":"Insurance","description":"H.R. 608: COVER Now Act expands health care coverage for those in states with no Medicaid expansion funds. H.R. 957: Parity Enforcement Act of 2025 create civil penalties for violating mental health parity requirements. -- H.R. 2082: WISH Act provides long-term care insurance benefits for seniors. H.R. 3758: Workers Disability Benefits Parity Act of 2025 mandates equal treatment of mental, behavioral, and physical health conditions in disability benefit plans. H.R. 6760: Protecting Access to Affordable Coverage Act: facilitating enrollment of qualified individuals in insurance plans S. 3698/H.R. 7227: Mental Health and MAMA Act of 2026 requires group health plans and insurers to provide mental health and substance use disorder services without cost-sharing for pregnant and postpartum individuals.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141549,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"MATTHEW","last_name":"LINSKEY","suffix":null,"suffix_display":null},"covered_position":"Legislative Correspondent for Debbie Wasserman Schultz 4/2005-10/2005","new":false},{"lobbyist":{"id":139015,"prefix":"ms","prefix_display":"MS.","first_name":"HANNAH","nickname":null,"middle_name":null,"last_name":"WESOLOWSKI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149684,"prefix":null,"prefix_display":null,"first_name":"JOANNA","nickname":null,"middle_name":null,"last_name":"ROSEN","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"H.R. 1096: HOPE and Mental Wellbeing Act of 2025 mandates coverage of three annual primary care visits without cost-sharing under Medicare and Medicaid. H.R. 1867: Removes in-person requirements for mental health services under Medicare. H.R. 1598: Ensuring Access to Medicaid Buy-in Programs Act lifts the age cap for Medicaid buy-in programs for those with disabilities who choose to work S. 752/H.R. 1509: Accelerating Kids Access to Care Act expands Medicaid enrollment across state lines. S. 683: More Behavioral Health Providers Act of 2025 creates workforce incentives under Medicare. H.R. 2540: SSI Savings Penalty Elimination Act updates resource limits for SSI income eligibility. Reject cuts to Medicaid and other mental health and or substance use disorder programs in the reconciliation process. Support for state waivers for federal financial participation for services furnished to Medicaid members during short-term stays for acute care in psychiatric hospitals or residential treatment facilities that qualify as institutions for mental disease. -- H.R. 1: One Big Beautiful Bill Act reauthorizes and reforms major federal programs including Medicaid. H.R. 2590: Mental and Physical Health Care Comorbidities Act of 2025 establishes a Medicare demonstration program to promote collaborative treatment of mental and physical health comorbidities. S. 1264/H.R. 3320: Strengthening Medicaid for Serious Mental Illness Act increases federal Medicaid funding for states providing intensive community-based services for adults with serious mental illness. H.R. 4022: Increasing Behavioral Health Treatment Act removes the Medicaid exclusion for mental health services in institutions for mental diseases for patients under 65. S. 2011/H.R. 3884: Telemental Health Care Access Act removes the statutory requirement that Medicare beneficiaries be seen in-person within six months of being treated for mental and behavioral health services through telehealth. S. 2024/H.R. 3907: Expand Navigators Resources for Outreach, Learning, and Longevity (ENROLL) Act strengthens and expands the navigator program by increasing funding, broadening duties, and ensuring nonprofit participation. H.R. 2495: Nutrition CARE Act of 2025 provides Medicare coverage for medical nutrition therapy for individuals with eating disorders. H.R. 2263: Telehealth Coverage Act of 2025: permanently expands telehealth services under Medicare H.R. 3384 Telemental Health Care Access Act: Expands Medicaid to include both mental and behavioral health services provided by telehealth. H.R. 4037/S.2847: Occupational Therapy Mental Health parity Act: Clarifies that Medicare covers occupational therapy for mental health and substance use disorders HR 4619 Medicare Mental Health Impatient Equity Act of 2025: Removes the 190-day lifetime limit on Medicare coverage on inpatient Psychiatric hospital services. HR 5462: Michelle Alyssa Go Act: Would expand Medicaid coverage for mental health and substance use disorder treatment by increasing the facility size limit from 16 to 36 beds. S. 2401/H.R. 4745: Medicaid Bump Act: Increase federal Medicaid funds for certain mental health services S. 1797 Expanding Seniors Access to Mental Health Services Act: expands Medicaid coverage and reimbursement for clinical social workers to provide mental health services S.2050 ASSIST Act: Increases federal Medicaid funding for school-based behavioral health services S.2069/HR 4028: Stabilize Medicaid and CHIP Coverage Act: mandates 12-month continuous enrollment for all individuals in Medicaid and CHIP S.2037/H.R.4313 Hospital Inpatient Services Modernization Act: Extends Medicare's acute hospital care at home waiver flexibilities S.2709/ H.R.5081: Telehealth Modernization Act: Extends and expands Medicare telehealth flexibilities S.3300/H.R.6408: ANCHOR Act of 2025 allows states to expand Medicaid coverage to low income, uninsured individuals with serious mental illness or substance use disorders S.3486 Expand the Behavioral Health Workforce Now Act: Requires federal guidance to help states strengthen the behavioral health workforce in Medicaid and CHIP S. 3522 No Red Tape for Addiction Treatment Act: Requires State Medicaid programs to cover at least one formulation of each medication for opioid use disorder without prior Authorization H.R. 6096 NEST Act funds and distributes essential newborn supply kits to mothers. S.1816/ H.R. 3514: Improving Seniors' Timely Access to Care Act: Streamlining prior authorization to increase timely access to care. Support for the extension of the enhanced advance premium tax credits (eAPTC) Support for an extension or permanent authorization of telehealth/telemental health flexibilities Support for continued access to Medicaid Ensuring that new community engagement requirements do not lead to individuals being unfairly removed from Medicaid. H.R. 7535: Second Chance Mental Health Access Act of 2026 requires Medicaid to cover 12 annual mental health telehealth visits for individuals transitioning from incarceration to home confinement. H.R. 5662: Improving Access to Institutional Mental Health Care Act removes the Medicaid exclusion for coverage of services provided to patients in mental health institutions. H.R. 6296: Advancing Access to Telehealth Act makes several telehealth flexibilities permanent under Medicare. H.R. 6727: Repealing the IMD Exclusion Act removes the Medicaid exclusion for mental health and substance use disorder treatment in institutions for mental diseases. H.R. 7324: More Behavioral Health Providers Act of 2026 expands Medicare bonus payments to a wider range of behavioral health practitioners. S. 2709: Telehealth Modernization Act extends and expands Medicare telehealth flexibilities. S. 3521/H.R. 6841: PEERS Act of 2025 expands Medicare to cover peer support services for mental health and substance use recovery. S. 3690: Ensuring Access to Medicaid Buy-in Programs Act of 2026 removes the age limit for working adults with disabilities to qualify for Medicaid buy-in programs. S. 3750: REAL Health Providers Act requires Medicare Advantage plans to maintain accurate provider directories. S. 4076: Removing Medicare Mental Health Inpatient Limitations Act of 2026 removes the 190-day lifetime limit on Medicare coverage for inpatient psychiatric hospital services. S. 4202: Mental Health Access and Provider Support Act of 2026 increases Medicare reimbursement rates for certain mental health providers.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141549,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"MATTHEW","last_name":"LINSKEY","suffix":null,"suffix_display":null},"covered_position":"Legislative Correspondent for Debbie Wasserman Schultz 4/2005- 10/2005","new":false},{"lobbyist":{"id":139015,"prefix":"ms","prefix_display":"MS.","first_name":"HANNAH","nickname":null,"middle_name":null,"last_name":"WESOLOWSKI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149684,"prefix":null,"prefix_display":null,"first_name":"JOANNA","nickname":null,"middle_name":null,"last_name":"ROSEN","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"VET","general_issue_code_display":"Veterans","description":"S.926/ H.R. 1987: Saving Our Veterans Lives Act authorizes a program through the Department of Veterans Affairs to provide free firearm lockboxes to veterans. H.R. 1290: Veterans Mental Health Crisis Referral Enhancement Act of 2025 creates program to refer veterans to non-VA providers. S. 219/H.R. 71: Veterans Health Care Freedom Act allows veterans to choose their health care providers. H.R. 438: PFC Joseph P. Dwyer Peer Support Program Act creates for grants for local peer to peer mental health programs. -- H.R. 1987: Saving Our Veterans Lives Act of 2025 establishes a VA program to provide veterans with secure firearm storage solutions. H.R. 2942: What Works for Preventing Veteran Suicide Act establishes standard practices for suicide prevention and mental health programs under the Veterans Health Administration. S. 585: Servicemember to Veteran Health Care Connection Act of 2025 establishes a pre-transition health care registration process for separating Armed Forces members. S. 609/H.R. 553: BRAVE Act requires the VA to establish a mental health care outreach system for veterans within two years. S. 702/H.R. 2426: Veterans Mental Health and Addiction Therapy Quality of Care Act requires a study comparing the quality of mental health and addiction therapy care between VA and non-VA providers. H.R. 3363 VA Mental Health Outreach and Engagement Act: requires the Department of Veterans Affairs to offer annual mental health consultations and conduct outreach for Veterans with service-connected mental health disabilities. H.R. 5040 Accurate Mental Health Resources for our Servicemembers Act: Requires military branches to review, update, and certify the accuracy of their online suicide prevention and behavioral health information. S.1655: Protecting Veterans in Crisis Act: Increasing oversight, reporting, and workforce protections for the Veterans Crisis Line. S.1912: Protecting Veterans Community Care Act: Expands and Safeguards veterans' access to community-based mental health and substance use services S2853/H.R. 5420 VA Extenders Act: Extends key Department of Veterans Affairs health care, benefits, and housing programs S.3042/H.R.3627 Justice for America's Veterans and Survivors Act: Mandates data on the cause of death among Veterans, including detailed data on service-connected disabilities and suicides S.3139 H.R. 6454: VA Zero Suicide Demonstration Project Act: Establishes a 5-year pilot program at select VA medical centers to implement the Zero Suicide Institutes' suicide prevention curriculum. H.R. 6000: Veterans Sentinel Act mandates improved data collection, analysis, and reporting on suicides and attempted suicides by veterans. H.R. 6383: Brandon Act Training and Protocol Act requires a strategic plan, protocols and training to improve mental health support and suicide prevention for Armed Forces members. H.R. 6858: Veteran Suicide Prevention Act mandates review of veteran suicides in VA care. H.R. 7049: Improving Mental Health Care and Coordination for Homeless Veterans Act requires the VA to assess and coordinate care for veterans identified as needing homeless services. H.R. 7735: Improving Mental Health Support for Servicemembers and Veterans Act requires an assessment of mental health support programs for servicemembers and veterans. S. 3245: MIND Our Veterans Act of 2025 requires validated mental health and substance use screenings for departing members. S. 3758: End Veterans Overdose Act of 2026 requires the VA to provide free opioid overdose rescue medications. S. 607: Improving Veteran Access to Care Act requires the VA to modernize and improve health care appointment scheduling for veterans.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":139015,"prefix":"ms","prefix_display":"MS.","first_name":"HANNAH","nickname":null,"middle_name":null,"last_name":"WESOLOWSKI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141549,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"MATTHEW","last_name":"LINSKEY","suffix":null,"suffix_display":null},"covered_position":"Legislative Correspondent for Debbie Wasserman Schultz 4/2005-10/2005","new":false},{"lobbyist":{"id":149684,"prefix":null,"prefix_display":null,"first_name":"JOANNA","nickname":null,"middle_name":null,"last_name":"ROSEN","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":42,"name":"Veterans Affairs, Dept of (VA)"}]},{"general_issue_code":"HOU","general_issue_code_display":"Housing","description":"H.R. 577: Treatment and Homelessness Housing Integration Act of 2024 allows referrals to community-based treatment. -- S. 1477/H.R. 2945: Housing for All Act of 2025 seeks to combat homelessness and the housing crisis by significantly increasing federal investments in affordable and supportive housing. Support for the renewal of HUD Continuum of Care Grants H.R. 6403: Homeless Children and Youth Act of 2025 expands definition of homelessness.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":141549,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"MATTHEW","last_name":"LINSKEY","suffix":null,"suffix_display":null},"covered_position":"Legislative Correspondent for Debbie Wassermann Schultz 4/2005-10/2005","new":false},{"lobbyist":{"id":139015,"prefix":"ms","prefix_display":"MS.","first_name":"HANNAH","nickname":null,"middle_name":null,"last_name":"WESOLOWSKI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149684,"prefix":null,"prefix_display":null,"first_name":"JOANNA","nickname":null,"middle_name":null,"last_name":"ROSEN","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/b61e96b2-3412-4795-9479-cc82759463cf/","filing_uuid":"b61e96b2-3412-4795-9479-cc82759463cf","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/b61e96b2-3412-4795-9479-cc82759463cf/print/","filing_document_content_type":"text/html","income":null,"expenses":"130000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Heather Strawn","dt_posted":"2026-04-16T15:47:11-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1455 Pennsylvania Ave NW","registrant_address_2":"Suite 400","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":400426042,"url":"https://lda.gov/api/v1/registrants/400426042/","house_registrant_id":null,"name":"LUNDBECK LLC","description":"Specialty and Central Nervous System Bio-pharmaceutical manufacturing","address_1":"1455 Pennsylvania Ave NW","address_2":"Suite 400","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"HEATHER STRAWN","contact_telephone":"+1 202-412-1563","dt_updated":"2026-07-29T13:14:27.156557-04:00"},"client":{"id":190625,"url":"https://lda.gov/api/v1/clients/190625/","client_id":12,"name":"LUNDBECK LLC","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2009-03-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues pertaining to the 340B Drug Discount Program - H.R. 5256, the 340B ACCESS Act; H.R.4581 & S. 2372, 340B PATIENTS Act of 2025 Issues pertaining to Pharmacy Benefit Managers - H.R.4317, PBM Reform Act of 2025; H.R.6703, Lower Health Care Premiums for All Americans Act Step therapy reform - H.R. 5509 & S. 2903, Safe Step Act Neuroscience Drug Program - FY 2026 and FY2027 AgFDA Appropriations BRAIN Initiative - FY 2026 and FY2027 Labor-HHS Appropriations Reauthorization of the Pediatric Priority Review Voucher program at the FDA Issues related to DTC advertising regulations Pediatric rare diseases - H.R. 1262 & S. 932, Give Kids a Chance Act of 2025 Headache disorders treatment and research - H.R. 5536, HEADACHE Act of 2025 Research and services for epilepsy - H.R. 1189 & S. 494, National Plan for Epilepsy Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":66159,"prefix":null,"prefix_display":null,"first_name":"HEATHER","nickname":null,"middle_name":null,"last_name":"STRAWN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143282,"prefix":null,"prefix_display":null,"first_name":"HAYLEY","nickname":null,"middle_name":null,"last_name":"ALEXANDER","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":152053,"prefix":null,"prefix_display":null,"first_name":"ZACHARY","nickname":null,"middle_name":null,"last_name":"POSS","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":153397,"prefix":null,"prefix_display":null,"first_name":"DARBIN","nickname":null,"middle_name":null,"last_name":"WOFFORD","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues pertaining to the 340B Drug Discount Program - H.R. 5256, 340B ACCESS Act; H.R.4581 & S. 2372, 340B PATIENTS Act of 2025 Issues pertaining to the implementation of the Inflation Reduction Act of 2022 - H.R. 6166, Lowering Drug Costs for American Families Act Issues pertaining to Pharmacy Benefit Managers - S.3345, PBM Price Transparency and Accountability Act; H.R.4317, PBM Reform Act of 2025 Issues pertaining to CMS Coverage of APS in LTC Issues pertaining to Medicares Six Protected Classes policy Medicare Part D Smoothing Benefit - FY 2026 and FY2027 Labor-HHS Appropriations Orphan drug exclusion in the Inflation Reduction Act - H.R. 946 & S. 1862, ORPHAN Cures Act Small molecule discrepancy in the Inflation Reduction Act - H.R. 1492 & S. 832, The EPIC Act Issues pertaining to the Most Favored Nation drug price setting policy - H.R. 7837, Most Favored Patient Act of 2026 Issues pertaining to migraine screening for women in Medicare - FY 2026 and FY2027 Labor-HHS Appropriations","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":66159,"prefix":null,"prefix_display":null,"first_name":"HEATHER","nickname":null,"middle_name":null,"last_name":"STRAWN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143282,"prefix":null,"prefix_display":null,"first_name":"HAYLEY","nickname":null,"middle_name":null,"last_name":"ALEXANDER","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":152053,"prefix":null,"prefix_display":null,"first_name":"ZACHARY","nickname":null,"middle_name":null,"last_name":"POSS","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":153397,"prefix":null,"prefix_display":null,"first_name":"DARBIN","nickname":null,"middle_name":null,"last_name":"WOFFORD","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Tariffs on pharmaceutical products","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":143282,"prefix":null,"prefix_display":null,"first_name":"HAYLEY","nickname":null,"middle_name":null,"last_name":"ALEXANDER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":66159,"prefix":null,"prefix_display":null,"first_name":"HEATHER","nickname":null,"middle_name":null,"last_name":"STRAWN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152053,"prefix":null,"prefix_display":null,"first_name":"ZACHARY","nickname":null,"middle_name":null,"last_name":"POSS","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":153397,"prefix":null,"prefix_display":null,"first_name":"DARBIN","nickname":null,"middle_name":null,"last_name":"WOFFORD","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/2cc79e15-9bc4-4964-8548-7e08d69a08b5/","filing_uuid":"2cc79e15-9bc4-4964-8548-7e08d69a08b5","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/2cc79e15-9bc4-4964-8548-7e08d69a08b5/print/","filing_document_content_type":"text/html","income":null,"expenses":"4420000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Jennie Skelton","dt_posted":"2026-04-17T20:38:17-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1275 Pennsylvania Avenue, NW","registrant_address_2":"Suite 501","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":31326,"url":"https://lda.gov/api/v1/registrants/31326/","house_registrant_id":31354,"name":"PFIZER INC.","description":"Biopharmaceuticals","address_1":"1275 Pennsylvania Avenue, NW","address_2":"Suite 501","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JENNIE SKELTON","contact_telephone":"+1 415-903-2800","dt_updated":"2026-08-21T13:00:31.079287-04:00"},"client":{"id":138225,"url":"https://lda.gov/api/v1/clients/138225/","client_id":12,"name":"PFIZER INC.","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2018-02-15"},"lobbying_activities":[{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"Intellectual Property Protections","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":106110,"prefix":null,"prefix_display":null,"first_name":"FRANCISCO","nickname":null,"middle_name":null,"last_name":"CARRILLO","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Vaccine Coverage Pediatric Immunization Schedule Vaccine Injury Compensation Program Executive Order 14297 - Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients H.R. 7837 - Most Favored Patient Act of 2026 Lyme Disease Issues 340B Issues Counterfeit Drugs Inflation Reduction Act (IRA) Prescription Drug User Fee Act (PDUFA) Drug Pricing PBM Reform Direct-to-Patient Prescription Drug Purchase Platforms and Insurance Coverage H.R. 5509 - Safe Step Act S. 2903 - Safe Step Act S. 3510 - Biosimilar Inspection Modernization Act of 2025","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":106110,"prefix":null,"prefix_display":null,"first_name":"FRANCISCO","nickname":null,"middle_name":null,"last_name":"CARRILLO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68817,"prefix":null,"prefix_display":null,"first_name":"EMILY","nickname":null,"middle_name":null,"last_name":"MUELLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":106111,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"STROIA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138233,"prefix":"ms","prefix_display":"MS.","first_name":"JENNIFER","nickname":null,"middle_name":"SWENSON","last_name":"WALTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143695,"prefix":"mrs","prefix_display":"MRS.","first_name":"ANGELA","nickname":null,"middle_name":"BOOTHE","last_name":"WILES","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":11,"name":"Executive Office of the President (EOP)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Executive Order 14297 - Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients Prescription Drug User Fee Act (PDUFA) 340B Issues Direct-to-Patient Prescription Drug Purchase Platforms and Insurance Coverage PBM Reform Counterfeit Drugs P.L. 117-169 - Inflation Reduction Act (IRA) of 2022 Drug Pricing Medicare/Medicaid Issues","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":68817,"prefix":null,"prefix_display":null,"first_name":"EMILY","nickname":null,"middle_name":null,"last_name":"MUELLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":106111,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"STROIA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138233,"prefix":"ms","prefix_display":"MS.","first_name":"JENNIFER","nickname":null,"middle_name":"SWENSON","last_name":"WALTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143695,"prefix":"mrs","prefix_display":"MRS.","first_name":"ANGELA","nickname":null,"middle_name":"BOOTHE","last_name":"WILES","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"International Supply Chain Market Access Most Favored Nation Policies Foreign Freeriding Issues Non-Tariff Trade Barriers Competiveness Issues Trade Issues","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":72512,"prefix":null,"prefix_display":null,"first_name":"STEPHEN","nickname":null,"middle_name":null,"last_name":"CLAEYS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68817,"prefix":null,"prefix_display":null,"first_name":"EMILY","nickname":null,"middle_name":null,"last_name":"MUELLER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69774,"prefix":null,"prefix_display":null,"first_name":"CATHERINE","nickname":null,"middle_name":null,"last_name":"ROBINSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":106111,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"STROIA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138233,"prefix":"ms","prefix_display":"MS.","first_name":"JENNIFER","nickname":null,"middle_name":"SWENSON","last_name":"WALTON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143695,"prefix":"mrs","prefix_display":"MRS.","first_name":"ANGELA","nickname":null,"middle_name":"BOOTHE","last_name":"WILES","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":22,"name":"U.S. Trade Representative (USTR)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/2147d217-3c07-4791-aa43-a6065c5cf34c/","filing_uuid":"2147d217-3c07-4791-aa43-a6065c5cf34c","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/2147d217-3c07-4791-aa43-a6065c5cf34c/print/","filing_document_content_type":"text/html","income":null,"expenses":"2300000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Julie Nickson","dt_posted":"2026-04-20T12:21:45-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"655 15th St, NW","registrant_address_2":"Suite 503","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":288670,"url":"https://lda.gov/api/v1/registrants/288670/","house_registrant_id":37100,"name":"AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC.","description":null,"address_1":"655 15th St, NW","address_2":"Suite 503","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JULIE NICKSON","contact_telephone":"+1 202-320-3064","dt_updated":"2026-07-28T09:35:13.201222-04:00"},"client":{"id":177221,"url":"https://lda.gov/api/v1/clients/177221/","client_id":12,"name":"AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-14"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Access to Care One Big Beautiful Bill, P.L. 119-21. Advocate to protect cancer patients in implementation of changes to Medicaid under the law. Health Care Affordability Act, H.R.247, S.46. Bill would permanently extend the enhanced Affordable Care Act tax credits. Association Health Plans Act, H.R.2528, S.1847. This bill would amend the Employee Retirement Income Security Act of 1974 to treat association health plans as employers. Self-Insurance Protection Act, H.R. 2571. This bill would amend the Employee Retirement Income Security Act of 1974 to exclude from the definition of health insurance coverage certain medical stop-loss insurance. Access to Breast Cancer Diagnosis Act, H.R. 3037/S.1500. To amend title XXVII of the Public Health Service Act to prohibit group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements with respect to diagnostic and supplemental breast examinations. Women and Lung Cancer Research and Preventative Services Act of 2025, H.R.2319, S.1157. This bill requires the Department of Health and Human Services working with the Department of Defense, to conduct an interagency review to evaluate the status of and identify opportunities for research on women and lunch cancer preventative services. Safe Step Act, H.R. 5509, S. 2903. Bill would require an exceptions process for any medication step therapy protocol in commercial insurance plans. Bipartisan Premium Tax Credit Extension Act, H.R. 5145, Bill would extend the enhanced ACA tax credits for one year. Breaking the Gridlock Act, H.R. 1834. Bill would extend the enhanced Affordable Care Act tax credits for three years. Common Ground for Affordable Health Care Act, H.R.6575. Bill would extend the enhanced Affordable Care Act tax credits for one year and make other adjustments. Bipartisan Health Insurance Affordability Act, H.R.6501. Bill would extend the enhanced Affordable Care Act tax credits for two years and make other adjustments. Medically Tailored Home-Delivered Meals Demonstration Pilot Act, H.R.5439, S.2834. The bill would create a pilot program in Medicare for beneficiaries with diet-related diseases to receive medically tailored meals to their own home. Womens Health and Cancer Rights Modernization Act of 2025, H.R.5813. This bill amends the Womens Health & Cancer Rights Act to require that commercial health plans provide coverage of breast or wall reconstruction provided as part of breast cancer treatment. HELP Copays Act, H.R. 6423, S. 864. Bill would apply financial assistance towards the cost-sharing requirements of health insurance plans. Health Disparities Nancy Gardner Sewell Medicare Early Detection Screening Coverage Act, P.L. 119-75. Legislation to improve access to new and innovative cancer screenings for Medicare beneficiaries by creating a pathway to allow Medicare to initiate coverage of multi-cancer tests following FDA approval if a clinical benefit is shown. Screening for Communities to Receive Early and Equitable Needed Services (SCREENS for Cancer Act, H.R. 2381, S.1866. Reauthorizes the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) through 2030 to provide the program greater flexibility in providing access to lifesaving screening, diagnostic, and treatment services and continue its innovative work aimed to reduce disparities and advance health equity in breast and cervical cancer. Education and Awareness Requires Learning Young (EARLY) Act, H.R. 4541, S. 2339. This bill would reauthorize the CDC program that supports young and high-risk women as well as their providers to better understand breast health. Prostate-Specific Antigen Screening for High-Risk Insured Men (PSA Screening for HIM) Act, H.R. 1300, S. 297. Legislation to remove cost sharing of PSA testing for those at the highest risk of being diagnosed with prostate cancer. Lung Cancer Screening and Prevention Act, H.R.1406. To amend title XVIII of the Social Security Act to authorize the coverage of additional lung cancer screening tests under the Medicare program. Data Equity. Legislative and regulatory funding to support the collection of detailed demographic data toward reducing disparities in cancer prevention, detection, and treatment. Prevent HPV Cancer Act of 2025, H.R. 6561. This bill would create a national public awareness campaign to promote education and awareness of HPV and HPV-associated cancers and would increase funding for the NBCCED program to boost breast and cervical cancer screening. Childhood Cancer Childhood Cancer Survivorship, Treatment, Access, and Research Reauthorization Act (STAR) Act. Continued implementation and funding of the Childhood Cancer STAR Act to promote the development of new, safer therapies for children with cancer. Our appropriations request includes $30 million for the Childhood Cancer STAR Act and $50 million for the Childhood Cancer Data Initiative. Accelerating Kids Access to Care Act, P.L. 119-75. Legislation that alleviates these burdens for families and providers by facilitating coordination across state lines and clarifying the process by which state Medicaid programs can cover specialized treatment regardless of where the child lives and where their care is received. Give Kids and Chance Act of 2025, P.L. 119-75. Legislation that would accelerate pediatric cancer treatments and expand access to live-saving therapies for children battling rare diseases, spur drug development for pediatric rare diseases, improve outcomes for patients, and close gaps in pediatric drug research. One Big Beautiful Bill, P.L. 119-21, Advocate to protect pediatric cancer patients in implementation of changes to Medicaid under the law. Quality of Life Palliative Care Palliative Care and Hospice Education and Training Act (PCHETA), S. 22870, H.R. 4425. Legislation to facilitate access to palliative care and coordinated care management. Palliative Care Research Funding. Funding to focus and expand national research programs in palliative care at the National Institutes of Health. Specifically, ACS CAN is working to include funding for palliative care research in the FY26 LHHS Appropriations bill. Federal Health Care Programs Department of Defense Cancer Research Funding. Ensure continued funding for cancer research within the DOD's Congressionally Directed Medical Research Program. Clinical Trials Clinical Trial Modernization Act, H.R. 3521. Increase access to clinical trials for all persons with cancer to participate by reducing barriers to enrollment including support for and remote access to trials. To amend the Internal Revenue Act of 1986 to exclude from gross income certain compensation to clinical trial participants, and for other purposes, H.R. 4184. Legislation to amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13) (2002 - 2022)","new":false},{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D - MI 13) (2005 - 2010); Legislative Director, Rep. Frederica Wilson (D - FL 24) (2011)","new":false},{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1)(2007-2023); Intern, Senator Barack Obama (D-IL)(2005).","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"One Big Beautiful Bill Act, P.L.119-21. Advocate to protect cancer patients in implementation of changes to Medicaid under the law. Issues regarding expanding the availability of the charitable deduction for non-itemizers. Issues respecting charitable giving and life income planning, issues regarding taxation of charitable organizations, and issues regarding economic relief for nonprofit organizations. Issues related to stimulus for nonprofit organizations and increasing charitable giving. Clinical Trial Modernization Act, H.R. 3521. Increase access to clinical trials for all persons with cancer to participate by reducing barriers to enrollment including support for ancillary (non-medical) costs and remote access to trials. To amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants, and for other purposes, H.R. 4184. Legislation to amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants. Health Care Affordability Act, H.R. 247, S. 46. Bill would permanently extend the enhanced Affordable Care Act tax credits. Bipartisan Premium Tax Credit Extension Act, H.R. 5145. Bill would extend the enhanced ACA tax credits for one year. Breaking the Gridlock Act, H.R. 1834. Bill would extend the enhanced Affordable Care Act tax credits for three years. CommonGround for Affordable Health Care Act, H.R.6575. Bill would extend the enhanced Affordable Care Act tax credits for one year and make other adjustments. Bipartisan Health Insurance Affordability Act, H.R.6501. Bill would extend the enhanced Affordable Care Act tax credits for two years and make other adjustments. A bill to amend the Internal Revenue Code of 1986 to extend the temporary enhanced premium credits, S.2824. Bill would extend the enhanced ACA tax credits for two years.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1)(2007-2023); Intern,Senator Barack Obama (D-IL)(2005).","new":false},{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13) (2002-2022)","new":false},{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D-MI 13) (2005-2010) Legislative Director, Rep. Frederica Wilson (D-FL 24) (2011)","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TOB","general_issue_code_display":"Tobacco","description":"Issues relating to smoking cessation, age of sale of tobacco products, tobacco taxes, graphic warning labels, product regulation, and smoke-free environments.; Issues relating to FDA regulation of flavors, electronic cigarettes and cigars. Strengthening Task Force Operations to Prevent Illicit Vaping Act (STOP Illicit Vaping Act), H.R.6845, / S.3569, Bill would codify and strengthen the federal multi-agency task force, led by the Department of Justice and Food and Drug Administration, to coordinate enforcement, information sharing, and strategy to combat the illegal importation, distribution, and sale of unauthorized e-cigarettes. Increasing Access to Lung Cancer Screening Act, H.R.6178. This legislation provides coverage without cost-sharing for lung cancer screening and tobacco cessation to those on Medicaid and codifies existing lung cancer screening requirements and eliminates prior authorization for those on Medicare and private insurance. Helping Tobacco Users Quit Act, S. 2064. This bill provides for coverage of certain tobacco cessation services, without cost-sharing, of diagnostic, therapy, and counseling services and pharmacotherapy, including prescription and nonprescription tobacco cessation agents, that are provided under medical supervision and in accordance with specified guidelines under Medicaid and Children's Health Insurance Program (CHIP).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D - MI 13) (2005 - 2010); Legislative Director, Rep. Frederica Wilson (D - FL 24) (2011)","new":false},{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1)(2007-2023); Intern, Senator Barack Obama (D-IL)(2005).","new":false},{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13)(2002-2022)","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"One Big Beautiful Bill Act, P.L.119-21. Advocate to protect cancer patients in implementation of changes to Medicaid under the law. FY26 Labor, Health, and Human Services funding provisions. ACS CAN advocated for full implementation of the law and for funding to be issued consistent with statute. FY27 House and Senate Labor, Health and Human Services legislation. ACS CAN advocates for increases in cancer research and prevention, including NIH, NCI, CDC DCPC, and OSH funding. FY25 Defense Appropriations for cancer programs with CDMRP. ACS CAN advocates for cancer research funding within CDMRP and funding for the Initiative for Improving Native American Cancer Outcomes through NCIs coordination with NIMHD. FY27 Defense Appropriations for cancer programs with CDMRP. ACS CAN advocates for cancer research funding within CDMRP. ACS CAN advocates for increases in programs that advance research for cancers include the Peer Reviewed Cancer Research Program (PRCRP). FY27 Interior Appropriations for Indian Health Services funding. ACS CAN advocates for increased funding for health with a focus on cancer funding. FY27 Agriculture and FDA Appropriations for issues related to drug shortages and tobacco. ACS CAN advocates for funding for the FDA, for provisions to address drug shortages, and on tobacco policy including issues related to the FDA regulation of flavors, electronic cigarettes, and cigars and cessation therapies as well as language to reduce drug shortages and fully implement FDORA. Indian Programs Advance Appropriations Act of 2025, S. 2771, H.R. 5328. The bill would provide advance appropriations authority for certain accounts of the Bureau of Indian Affairs and Bureau of Indian Education of the Department of the Interior and the Indian Health Service.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13) (2002 - 2022)","new":false},{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1)(2007-2023); Intern, Senator Barack Obama (D-IL)(2005).","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D-MI 13) (2005-2010), Legislative Director, Rep. Frederica Wilson (D-FL 24) (2011)","new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"One Big Beautiful Bill Act, P.L.119-21. Advocate to protect cancer patients in implementation of changes to Medicaid under the law. Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act, P.L. 119-75. Legislation to improve access to new and innovative cancer screenings for Medicare beneficiaries by creating a pathway to allow Medicare to initiate coverage of multi-cancer tests following FDA approval if a clinical benefit is shown. Lung Cancer Screening and Prevention Act, H.R. 140. To amend title XVIII of the Social Security Act to authorize the coverage of additional lung cancer screening tests under the Medicare program. Accelerating Kids Access to Care Act, P.L. 119-75. Legislation that alleviates these burdens for families and providers by facilitating coordination across state lines and clarifying the process by which state Medicaid programs can cover specialized treatment regardless of where the child lives and where their care is received. Ensuring Access to Essential Providers Act, S.2793. Bill would require Medicare Advantage plans to cover items and services furnished by certain essential community providers. Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act, H.R. 5269, S. 2761. Bill would address Medicare reimbursement of laboratory services. Access to Genetic Counselor Services Act, H.R.6280. Bill would expand coverage of genetic counseling services under Medicare. Lung Cancer Screening and Prevention Act of 2025, H.R. 1406. This bill authorizes Medicare coverage of additional types of lung cancer screening tests that are approved by the FDA, regardless of whether they are recommended by the United States Preventive Services Task Force (USPSTF). Increasing Access to Lung Cancer Screening Act, H.R.6178. This legislation provides coverage without cost-sharing for lung cancer screening and tobacco cessation to those on Medicaid and codifies existing lung cancer screening requirements and eliminates prior authorization for those on Medicare and private insurance.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D - MI 13) (2005 - 2010); Legislative Director, Rep. Frederica Wilson (D - FL 24) (2011)","new":false},{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1)(2007-2023); Intern,Senator Barack Obama (D-IL)(2005).","new":false},{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13) (2002-2022)","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Clinical Trial Modernization Act, H.R. 3521. Increase access to clinical trials for all persons with cancer to participate by reducing barriers to enrollment, including support for ancillary (non-medical) costs. To amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants, and for other purposes, H.R. 4184. Legislation to amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants. Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act, H.R. 5269, S. 2761. Bill would address Medicare reimbursement of laboratory services. Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act, P.L. 119-75. Legislation to improve access to new and innovative cancer screenings for Medicare beneficiaries by creating a pathway to allow Medicare to initiate coverage of multi-cancer tests following FDA approval if a clinical benefit is shown.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D - MI 13) (2005 - 2010); Legislative Director, Rep. Frederica Wilson (D - FL 24) (2011)","new":false},{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1) (2007-2023); Intern, Senator Barack Obama (D-IL) (2005)","new":false},{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13) (2002-2022)","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"Defense Appropriations. ACS CAN advocates for cancer research funding within CDMRP.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1)(2007-2023); Intern, Senator Barack Obama (D-IL)(2005).","new":false},{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D - MI 13) (2005 - 2010); Legislative Director, Rep. Frederica Wilson(D - FL 24) (2011)","new":false},{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13) (2002 - 2022)","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"IND","general_issue_code_display":"Indian/Native American Affairs","description":"Issues relating to Indian Health Services and the Congressional Native American Caucus. FY27 appropriations for the Indian Health Service. ACS CAN advocates for full funding for FY27 and advanced appropriations to ensure American Indians and Alaska Natives have access to quality and affordable health care services. Indian Programs Advance Appropriations Act of 2025, S. 2771, H.R. 5328. The bill would provide advance appropriations authority for certain accounts of the Bureau of Indian Affairs and Bureau of Indian Education of the Department of the Interior and the Indian Health Service. FY27 appropriations for the Initiative for Improving Native American Cancer Outcomes under the NIMHD and NCI. ACS CAN advocates for the continuation of full funding for the program to support research, education, outreach, and clinical access related to cancer in Native American populations.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":142553,"prefix":null,"prefix_display":null,"first_name":"NISHITH","nickname":null,"middle_name":null,"last_name":"PANDYA","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Bobby L. Rush (D-IL 1)(2007-2023); Intern, Senator Barack Obama (D-IL)(2005).","new":false},{"lobbyist":{"id":144403,"prefix":null,"prefix_display":null,"first_name":"MARC","nickname":null,"middle_name":null,"last_name":"GOTTSCHALK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140682,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":null,"last_name":"NICKSON","suffix":null,"suffix_display":null},"covered_position":"Chief of Staff, U.S. Representative Barbara Lee (D-CA 13) (2002-2022)","new":false},{"lobbyist":{"id":140683,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"WILLIAMS","suffix":"jr","suffix_display":"JR"},"covered_position":"Deputy Chief of Staff & Appropriations Staff, U.S. Representative Carolyn Kilpatrick (D-MI 13) (2005-2010), Legislative Director, U.S. Representative Frederica Wilson (D-FL 24) (2011)","new":false},{"lobbyist":{"id":149571,"prefix":null,"prefix_display":null,"first_name":"ELIZABETH","nickname":null,"middle_name":null,"last_name":"DARNALL","suffix":null,"suffix_display":null},"covered_position":"Special Assistant to the President and Senate Legislative Liaison, Executive Office of the President (2023-2025); Senior Health Policy Advisor, Senator Patty Murray (D-WA) (2023); Senior Health Policy Advisor, HELP Committee (2022).","new":false},{"lobbyist":{"id":151140,"prefix":"mr","prefix_display":"MR.","first_name":"ALEXANDER","nickname":null,"middle_name":"JOSHUA","last_name":"SUTTON","suffix":null,"suffix_display":null},"covered_position":"Professional Staff Member, U.S. Representative Mario Diaz-Balart (R-FL 25) (2023-2024)","new":false},{"lobbyist":{"id":151786,"prefix":null,"prefix_display":null,"first_name":"ERIKA","nickname":null,"middle_name":null,"last_name":"NINOYU","suffix":null,"suffix_display":null},"covered_position":"Deputy Director & Sr. Advisor, White House Initiative on Asian Americans, Native Hawaiians and Pacific Islanders (2023-2025); Sr. Leg. Asst. U.S. Rep. Barbara Lee (D-CA-13) (2020-2023); Fellow, U.S. Rep. Grace Meng (D-NY-06) (2020).","new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/d0e388d9-ef9b-4656-96b2-763e38b6a702/","filing_uuid":"d0e388d9-ef9b-4656-96b2-763e38b6a702","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/d0e388d9-ef9b-4656-96b2-763e38b6a702/print/","filing_document_content_type":"text/html","income":null,"expenses":"10000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Nicolette Tapay","dt_posted":"2026-04-20T12:58:36-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1801 Research Blvd., Suite 400","registrant_address_2":null,"registrant_different_address":true,"registrant_city":"ROCKVILLE","registrant_state":"MD","registrant_zip":"20850","registrant":{"id":71952,"url":"https://lda.gov/api/v1/registrants/71952/","house_registrant_id":35955,"name":"ASSOCIATION OF CANCER CARE CENTERS (FKA ASSOCIATION OF COMMUNITY CANCER CENTERS)","description":null,"address_1":"1801 Research Blvd., Suite 400","address_2":null,"address_3":null,"address_4":null,"city":"ROCKVILLE","state":"MD","state_display":"Maryland","zip":"20850","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"LEAH RALPH","contact_telephone":"+1 301-984-9496","dt_updated":"2026-07-27T15:04:38.432380-04:00"},"client":{"id":165520,"url":"https://lda.gov/api/v1/clients/165520/","client_id":12,"name":"ASSOCIATION OF CANCER CARE CENTERS (FKA ASSOCIATION OF COMMUNITY CANCER CENTERS)","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"MD","state_display":"Maryland","country":"US","country_display":"United States of America","ppb_state":"MD","ppb_state_display":"Maryland","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-03"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Health care priorities of ACCC: a) Prior authorization (Including: Improving Seniors Timely Access to Care Act of 2025 (S.1816/ H.R. 3514); 2) Oncology drug and medical supply shortages; 4) Financial toxicity for cancer patients; 5) Inflation Reduction Act implementation, especially Protecting Patient Access to Cancer and Complex Therapies Act (H.R.4299); 6) Reducing Physician Payment Reimbursement Cuts; 7) Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act (H.R.842/S.339); 8) Extension of Medicare reimbursement for telehealth services (passed in Feb. as part of the Consolidated Appropriations Act of 2026); 9) Preserve Medicaid coverage for caregivers and other beneficiaries (mitigate potential impact of One Big Beautiful Bill Act (OBBBA) implementation on their coverage); 10) Safe Step Act (H.R. 5509/S. 2903); 11) Radiation Oncology Case Rate (ROCR) Value Based Program Act(H.R. 2120/S.1031); 12) Maintain and promote access to coverage (including renew ACA subsidies and mitigate impact of Medicaid changes in OBBBA); 13) Ensuring Access to Essential Providers Act of 2025 (S. 2793); 14) Access to Genetic Counselor Services Act (S. 3607/H.R. 6280); 15) Request to Designate April as Cancer Prevention and Early Detection month; 16) Modernize incentives for Advanced Alternative Payment Models (APMs); 17) Stabilize physician payment system and prepare for APMs; 18) Leverage the CMS Innovation Center; 19) Support Fiscal Year 2027 appropriations for these family caregiver support programs: National Family Caregiver Support Program, Lifespan Respite Care Program, Native American Caregiver Support Services, National Strategy Demonstration Grants; and 21) FY 2027 appropriations funding recommendations in support of the Department of Veterans Affairs (VA) Medical and Prosthetic Research Program, funding to address VA research infrastructure deficiencies, and dedicated funding for VA research information technology modernization.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":145536,"prefix":null,"prefix_display":null,"first_name":"NICOLETTE","nickname":null,"middle_name":null,"last_name":"TAPAY","suffix":null,"suffix_display":null},"covered_position":"Senior Health Policy Advisor, Senator Ron Wyden (6/2007-7/2009)","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/e5599c31-8974-466d-8ca6-96e0ff9fd99d/","filing_uuid":"e5599c31-8974-466d-8ca6-96e0ff9fd99d","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/e5599c31-8974-466d-8ca6-96e0ff9fd99d/print/","filing_document_content_type":"text/html","income":null,"expenses":"60000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"James Nichols","dt_posted":"2026-04-20T14:18:39-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"P.O. Box 75560","registrant_address_2":null,"registrant_different_address":true,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20013","registrant":{"id":87494,"url":"https://lda.gov/api/v1/registrants/87494/","house_registrant_id":36613,"name":"TOURETTE ASSOCIATION OF AMERICA","description":"Non Profit Organization","address_1":"P.O. Box 75560","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20013","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JAMES NICHOLS","contact_telephone":"+1 718-224-2999","dt_updated":"2026-07-20T13:55:01.219339-04:00"},"client":{"id":173559,"url":"https://lda.gov/api/v1/clients/173559/","client_id":12,"name":"TOURETTE ASSOCIATION OF AMERICA","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2017-07-10"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Public Health Education and Research Program on Tourette Syndrome at the Centers for Disease Control and Prevention and CDC Funding Broadly - Fiscal Year 2025 and 2026 H.R. 5304/S. 2587- FY 2026 Labor, Health and Human Services, and Education Appropriations Bill H.R. 7148- FY2026 Consolidated Appropriations Act Initial FY2027 budget work","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":148269,"prefix":"mr","prefix_display":"MR.","first_name":"JAMES","nickname":null,"middle_name":"DAVID","last_name":"NICHOLS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":243,"name":"Natl Institute of Mental Health (NIMH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"EDU","general_issue_code_display":"Education","description":"Education Disability Issues, including IDEA Act implementation ESSA (Every Student Succeeds Act) implementation Education needs and experiences of students with Tourette Syndrome, including pell grants and pell grant hour requirement flexibility for students with disabilities including TS General support for the Office of Special Education Programs","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":148269,"prefix":"mr","prefix_display":"MR.","first_name":"JAMES","nickname":null,"middle_name":"DAVID","last_name":"NICHOLS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":32,"name":"Education, Dept of"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Mental Health issues (incl. mental health parity, suicide prevention) General Health Care issues for people living with Tourette Syndrome or other Tic Disorders (preexisting coverage, Medicare/Medicaid) Medicare Part D Protected Class Drugs Coverage, Part D coverage Research, medical and scientific issues (including BRAIN initiative) Drug Pricing Broadly Telehealth (including HR 4206/ S 1261 - Connect for Health Act of 2025) H.R. 3514/S.1816- Improving Seniors Timely Access to Care Act of 2025 H.R. 5509/S. 2903- Safe Step Act of 2025 H.R. 1509/S. 752- Accelerating Kids Access to Care Act of 2025 H.R. 1262/S. 932- Give Kids a Chance Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":148269,"prefix":"mr","prefix_display":"MR.","first_name":"JAMES","nickname":null,"middle_name":"DAVID","last_name":"NICHOLS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Access to Care and Treatment Issues (step therapy, prior authorization, non-medical switching) Medicare Part D Protected Class Drugs, Part D coverage (including out of pocket maximum and smoothing mechanism implementation) Telehealth Coverage H.R. 3514/S. 1816- Improving Seniors Timely Access to Care Act H.R. 4206/S. 1261- Connect for Health Act of 2025 H.R. 1509/S. 752- Accelerating Kids Access to Care Act of 2025","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":148269,"prefix":"mr","prefix_display":"MR.","first_name":"JAMES","nickname":null,"middle_name":"DAVID","last_name":"NICHOLS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"LBR","general_issue_code_display":"Labor Issues/Antitrust/Workplace","description":"General Diversity, Equity, Inclusion and Accessibility in the Federal Workforce Issues.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":148269,"prefix":"mr","prefix_display":"MR.","first_name":"JAMES","nickname":null,"middle_name":"DAVID","last_name":"NICHOLS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/6120b9d2-352b-4762-bdb3-01e62c982226/","filing_uuid":"6120b9d2-352b-4762-bdb3-01e62c982226","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/6120b9d2-352b-4762-bdb3-01e62c982226/print/","filing_document_content_type":"text/html","income":null,"expenses":"600000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Cathleen Gates","dt_posted":"2026-04-20T15:43:45-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"2400 N Street, NW","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20037","registrant":{"id":1945,"url":"https://lda.gov/api/v1/registrants/1945/","house_registrant_id":30532,"name":"AMERICAN COLLEGE OF CARDIOLOGY","description":null,"address_1":"2400 N Street, NW","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20037","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"LUCAS SANDERS","contact_telephone":"+1 202-375-6397","dt_updated":"2026-07-29T12:01:27.325680-04:00"},"client":{"id":102667,"url":"https://lda.gov/api/v1/clients/102667/","client_id":12,"name":"AMERICAN COLLEGE OF CARDIOLOGY","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-09-28"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Health care quality; physician and hospital quality; health care innovation; Patient Protection and Affordable Care Act/health care reform implementation; unique device identifier policy and post-market surveillance for medical devices; clinical trial design; HIPAA and registries; federal funding/appropriations for HHS, NIH, AHRQ, CDC, FDA, HRSA and the Childrens Hospital Graduate Medical Education payment program, the Prevention & Public Health Fund, medical research, and prevention; research and scholarly communication policy; implementation and oversight of 21st Century Cures Act; data blocking/interoperability of electronic data; artificial intelligence/machine learning; algorithm transparency; health disparities; reduction/oversight of prior authorization and other administrative burdens; digital health; Sect. 1557 Nondiscrimination in Health Programs and Activities; cardiomyopathy education and awareness; peripheral arterial disease (PAD) education and awareness; VA Mission Act implementation; COVID-19 and implementation of the Coronavirus Preparedness and Response Supplemental Appropriations Act, the Families First Coronavirus Response Act , the Coronavirus Aid, Relief, and Economic Security Act, Coronavirus Provider Protection Act, and clinician mental health and wellbeing; patient identification; Pandemic and All Hazards Preparedness; MCIT/TCET/Breakthrough devices; Amputation Reduction and Compassion (ARC) Act (H.R. 307); Resident Education Deferred Interest (REDI) Act (H.R. 2028/S. 942); Implementation and funding for the Cardiomyopathy Health, Education, Awareness, Research and Training in Schools (HEARTS) Act (P.L. 118-176); provide AEDs in transportation facilities with the Public Access to Defibrillation in Transportation Facilities Act (H.R. 5897); Lorna Breen Health Care Provider Protection Reauthorization Act (H.R. 929/S. 266; Physician Led and Rural Access to Access to Quality Care Act (H.R. 2191/S. 1390); Section 232, National Security Investigation of Imports of Pharmaceuticals and Pharmaceutical Ingredients; and to protect health care workers from violence with the Save Healthcare Workers Act (H.R. 3178/S. 1600).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":139239,"prefix":"mr","prefix_display":"MR.","first_name":"NOIA","nickname":null,"middle_name":"NICHOLAS","last_name":"MORSE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":54728,"prefix":"mr","prefix_display":"MR.","first_name":"LUCAS","nickname":null,"middle_name":"ROBERT","last_name":"SANDERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70525,"prefix":null,"prefix_display":null,"first_name":"JOHNATHON","nickname":null,"middle_name":null,"last_name":"KRISTAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":54536,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"VAVRICEK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139515,"prefix":"mr","prefix_display":"MR.","first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"MINNELLA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148563,"prefix":"ms","prefix_display":"MS.","first_name":"AMANDA","nickname":null,"middle_name":null,"last_name":"CAVALLO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143678,"prefix":"mr","prefix_display":"MR.","first_name":"FOSTER","nickname":null,"middle_name":"PATRICK","last_name":"CURRY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147772,"prefix":null,"prefix_display":null,"first_name":"ADRIENNE","nickname":null,"middle_name":null,"last_name":"MORTIMER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153653,"prefix":null,"prefix_display":null,"first_name":"FAIZAH","nickname":null,"middle_name":null,"last_name":"PIRZADA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":132,"name":"Agency for Healthcare Research & Quality (AHRQ)"},{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"The One Big Beautiful Bill Act, H.R. 1; Medicare physician payment including, the Medicare Patient Access and Practice Stabilization Act (H.R. 879); the Strengthening Medicare for Patients and Providers Act (H.R. 6160), the Provider Reimbursement Stability Act (S. 4935); the Provider Reimbursement Stability Act (H.R. 8163); and the Efficiency Adjustment Delay Act (H.R. 7520); new/alternative payment models; Medicare coverage, hospital payment of cardiovascular services; access to Medicare claims data; physician and hospital quality; Quality Payment Program; clinical data registries; health care quality; medical imaging and prior authorization; the Stark Law and the in-office ancillary services exception; Medicare Access and CHIP Reauthorization Act implementation and oversight; Bipartisan Budget Act of 2015 and Medicare site of service policy; graduate medical education policy including the Resident Physician Shortage Reduction Act (H.R. 3890/S. 2439); provide a specialty physician loan repayment program with the SPARC Act (H.R 4681/S. 1380); provide deferred interest payments for residents on student loans with the Resident Education Deferred Interest (REDI) Act (H.R. 2028/S. 942); oversight and implementation of the Protecting Access to Medicare Act of 2014, including Appropriate Use Criteria; physician-owned hospital policy including the Physician Led Rural Access to Quality Care Act (H.R. 2191/S. 1390) and the Patient Access to Higher Quality Health Care Act (H.R. 4002); COVID-19 public health emergency and the implementation of the Coronavirus Preparedness and Response Supplemental Appropriations Act, the Families First Coronavirus Response Act, the Coronavirus Aid, Relief, and Economic Security Act; implementation of the Protecting Medicare and American Farmers from Sequester Cuts Act; Increasing Access to Quality Cardiac Rehabilitation Care Act; the expansion of telehealth services, including the CONNECT for Health Act (H.R. 41894206/S. 1261), the Sustainable Cardiopulmonary Rehabilitation Services in the Home At (H.R. 783/S. 248), and the Telehealth Modernization Act (H.R. 5081/S. 2709); Improving maternal health, including Connected Maternal Online Monitoring Act (Connected MOM Act) (H.R. 4977/S. 141), Preventing Maternal Deaths Reauthorization Act of 2025 (H.R. 1909), and Rural Obstetrics Readiness Act (H.R. 1254/S. 380), and the Womens Heart Health Expansion Act (H.R. 7417/S. 3944) ; prior authorization reform, including the Improving Seniors Timely Access to Care Act (H.R. 3514/S. 1816), the Reducing Medically Unnecessary Delays in Care Act (H.R. 2433), and the Safe Step Act (H.R. 5509/S. 2903); clinician-led registry access to federal claims data, including the Access to Claims Data Act (H.R. 4331); and expanding in home prescribing coverage provided in the Increasing Access to Quality Cardiac Rehabilitation Care Act of 2025 (H.R. 6894/S. 717), Centers for Medicare and Medicaid Innovation payment models.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":139239,"prefix":"mr","prefix_display":"MR.","first_name":"NOIA","nickname":null,"middle_name":"NICHOLAS","last_name":"MORSE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":54728,"prefix":"mr","prefix_display":"MR.","first_name":"LUCAS","nickname":null,"middle_name":"ROBERT","last_name":"SANDERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":54536,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"VAVRICEK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148568,"prefix":"ms","prefix_display":"MS.","first_name":"DEBRA","nickname":null,"middle_name":null,"last_name":"MARIANI-WEISSENBORN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70525,"prefix":null,"prefix_display":null,"first_name":"JOHNATHON","nickname":null,"middle_name":null,"last_name":"KRISTAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139515,"prefix":"mr","prefix_display":"MR.","first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"MINNELLA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148563,"prefix":"ms","prefix_display":"MS.","first_name":"AMANDA","nickname":null,"middle_name":null,"last_name":"CAVALLO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143678,"prefix":"mr","prefix_display":"MR.","first_name":"FOSTER","nickname":null,"middle_name":"PATRICK","last_name":"CURRY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147772,"prefix":null,"prefix_display":null,"first_name":"ADRIENNE","nickname":null,"middle_name":null,"last_name":"MORTIMER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153653,"prefix":null,"prefix_display":null,"first_name":"FAIZAH","nickname":null,"middle_name":null,"last_name":"PIRZADA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":253,"name":"Medicare Payment Advisory Commission (MedPAC)"},{"id":18,"name":"Office of Management & Budget (OMB)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TOB","general_issue_code_display":"Tobacco","description":"Tobacco use prevention and smoking cessation; FDA regulation of tobacco; electronic cigarettes and nicotine products; tobacco and electronic cigarette policy in House and Senate Appropriations; Federal funding for the CDCs Office of Smoking and Health and chronic disease prevention.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":139239,"prefix":"mr","prefix_display":"MR.","first_name":"NOIA","nickname":null,"middle_name":"NICHOLAS","last_name":"MORSE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":54728,"prefix":"mr","prefix_display":"MR.","first_name":"LUCAS","nickname":null,"middle_name":"ROBERT","last_name":"SANDERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70525,"prefix":null,"prefix_display":null,"first_name":"JOHNATHON","nickname":null,"middle_name":null,"last_name":"KRISTAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":54536,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"VAVRICEK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148563,"prefix":"ms","prefix_display":"MS.","first_name":"AMANDA","nickname":null,"middle_name":null,"last_name":"CAVALLO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143678,"prefix":"mr","prefix_display":"MR.","first_name":"FOSTER","nickname":null,"middle_name":"PATRICK","last_name":"CURRY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147772,"prefix":null,"prefix_display":null,"first_name":"ADRIENNE","nickname":null,"middle_name":null,"last_name":"MORTIMER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153653,"prefix":null,"prefix_display":null,"first_name":"FAIZAH","nickname":null,"middle_name":null,"last_name":"PIRZADA","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/125765fc-df56-433f-bd28-e6ae08da30dd/","filing_uuid":"125765fc-df56-433f-bd28-e6ae08da30dd","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/125765fc-df56-433f-bd28-e6ae08da30dd/print/","filing_document_content_type":"text/html","income":null,"expenses":"2080000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Daniel Bachner","dt_posted":"2026-04-20T15:52:50-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1399 New York Avenue NW","registrant_address_2":"Suite 600","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":401049961,"url":"https://lda.gov/api/v1/registrants/401049961/","house_registrant_id":null,"name":"ABBVIE, INC.","description":"Biopharmaceutical company","address_1":"1399 New York Avenue NW","address_2":"Suite 600","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"DANIEL BACHNER","contact_telephone":"+1 202-383-9616","dt_updated":"2026-08-03T09:35:22.017305-04:00"},"client":{"id":197319,"url":"https://lda.gov/api/v1/clients/197319/","client_id":12,"name":"ABBVIE INC.","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2013-02-25"},"lobbying_activities":[{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"S.1040, Drug Competition Enhancement Act Patent litigation reform issues and issues related to post-grant proceedings at the USPTO Value of intellectual property","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":63900,"prefix":null,"prefix_display":null,"first_name":"DANIEL","nickname":null,"middle_name":null,"last_name":"BACHNER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62485,"prefix":null,"prefix_display":null,"first_name":"STEPHEN","nickname":null,"middle_name":null,"last_name":"SCANGO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":90411,"prefix":null,"prefix_display":null,"first_name":"DORCAS","nickname":null,"middle_name":null,"last_name":"ADEKUNLE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":106073,"prefix":null,"prefix_display":null,"first_name":"CRYSTAL","nickname":null,"middle_name":null,"last_name":"RILEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143495,"prefix":null,"prefix_display":null,"first_name":"RACHEL","nickname":null,"middle_name":null,"last_name":"DERBY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"S. 864, HELP Copays Act H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act S. 2903, Safe Step Act H.R. 5509, Safe Step Act Drug cost and pricing policy issues Patient affordability issues Issues related to the 340B program Issues related to data privacy Issues related to Hepatitis C elimination Issues related to FDA communications","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":62485,"prefix":null,"prefix_display":null,"first_name":"STEPHEN","nickname":null,"middle_name":null,"last_name":"SCANGO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":63900,"prefix":null,"prefix_display":null,"first_name":"DANIEL","nickname":null,"middle_name":null,"last_name":"BACHNER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":90411,"prefix":null,"prefix_display":null,"first_name":"DORCAS","nickname":null,"middle_name":null,"last_name":"ADEKUNLE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":106073,"prefix":null,"prefix_display":null,"first_name":"CRYSTAL","nickname":null,"middle_name":null,"last_name":"RILEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143495,"prefix":null,"prefix_display":null,"first_name":"RACHEL","nickname":null,"middle_name":null,"last_name":"DERBY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Public Law 117-169 (formerly known as H.R. 5376, Inflation Reduction Act) Implementation regarding Medicare Part D drug negotiation program Policy Proposals related to Medicare Part D and patient cost-sharing Department of Health and Human Services (HHS) drug policy issues and regulatory policy issues Issues related to HCV treatment","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":62485,"prefix":null,"prefix_display":null,"first_name":"STEPHEN","nickname":null,"middle_name":null,"last_name":"SCANGO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":63900,"prefix":null,"prefix_display":null,"first_name":"DANIEL","nickname":null,"middle_name":null,"last_name":"BACHNER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":90411,"prefix":null,"prefix_display":null,"first_name":"DORCAS","nickname":null,"middle_name":null,"last_name":"ADEKUNLE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":106073,"prefix":null,"prefix_display":null,"first_name":"CRYSTAL","nickname":null,"middle_name":null,"last_name":"RILEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143495,"prefix":null,"prefix_display":null,"first_name":"RACHEL","nickname":null,"middle_name":null,"last_name":"DERBY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"H.R. 1328, Supply Chain Security and Growth Act of 2025 H.R. 1990, American Innovation and R&D Competitiveness Act of 2025 Public Law No: 119-21 (formerly known as H.R. 1, One Big Beautiful Bill Act) Implementation Public Law 115-97 (formerly known as H.R. 1, Tax Cuts and Jobs Act) Implementation Policy proposals relating to economic activity in Puerto Rico International tax issues, including OECD digital taxation work program","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":63900,"prefix":null,"prefix_display":null,"first_name":"DANIEL","nickname":null,"middle_name":null,"last_name":"BACHNER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62485,"prefix":null,"prefix_display":null,"first_name":"STEPHEN","nickname":null,"middle_name":null,"last_name":"SCANGO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":90411,"prefix":null,"prefix_display":null,"first_name":"DORCAS","nickname":null,"middle_name":null,"last_name":"ADEKUNLE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":106073,"prefix":null,"prefix_display":null,"first_name":"CRYSTAL","nickname":null,"middle_name":null,"last_name":"RILEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143495,"prefix":null,"prefix_display":null,"first_name":"RACHEL","nickname":null,"middle_name":null,"last_name":"DERBY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"}]},{"general_issue_code":"LBR","general_issue_code_display":"Labor Issues/Antitrust/Workplace","description":"Issues related to antitrust and competition policy","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":63900,"prefix":null,"prefix_display":null,"first_name":"DANIEL","nickname":null,"middle_name":null,"last_name":"BACHNER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62485,"prefix":null,"prefix_display":null,"first_name":"STEPHEN","nickname":null,"middle_name":null,"last_name":"SCANGO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":90411,"prefix":null,"prefix_display":null,"first_name":"DORCAS","nickname":null,"middle_name":null,"last_name":"ADEKUNLE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":106073,"prefix":null,"prefix_display":null,"first_name":"CRYSTAL","nickname":null,"middle_name":null,"last_name":"RILEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143495,"prefix":null,"prefix_display":null,"first_name":"RACHEL","nickname":null,"middle_name":null,"last_name":"DERBY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Issues related to pharmaceutic tariffs and unfair trade practices Issues related to U.S. biotech competitiveness with China","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":63900,"prefix":null,"prefix_display":null,"first_name":"DANIEL","nickname":null,"middle_name":null,"last_name":"BACHNER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62485,"prefix":null,"prefix_display":null,"first_name":"STEPHEN","nickname":null,"middle_name":null,"last_name":"SCANGO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":90411,"prefix":null,"prefix_display":null,"first_name":"DORCAS","nickname":null,"middle_name":null,"last_name":"ADEKUNLE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":106073,"prefix":null,"prefix_display":null,"first_name":"CRYSTAL","nickname":null,"middle_name":null,"last_name":"RILEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143495,"prefix":null,"prefix_display":null,"first_name":"RACHEL","nickname":null,"middle_name":null,"last_name":"DERBY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":22,"name":"U.S. Trade Representative (USTR)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/e3beff28-2272-4f88-b28c-e7fa63e13ebd/","filing_uuid":"e3beff28-2272-4f88-b28c-e7fa63e13ebd","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/e3beff28-2272-4f88-b28c-e7fa63e13ebd/print/","filing_document_content_type":"text/html","income":null,"expenses":"3510000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Jane Adams","dt_posted":"2026-04-20T16:34:13-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"ONE JOHNSON & JOHNSON PLAZA","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"NEW BRUNSWICK","registrant_state":"NJ","registrant_zip":"08933","registrant":{"id":20686,"url":"https://lda.gov/api/v1/registrants/20686/","house_registrant_id":30348,"name":"JOHNSON & JOHNSON SERVICES, INC.","description":null,"address_1":"ONE JOHNSON & JOHNSON PLAZA","address_2":null,"address_3":null,"address_4":null,"city":"NEW BRUNSWICK","state":"NJ","state_display":"New Jersey","zip":"08933","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JANE ADAMS","contact_telephone":"+1 202-589-1000","dt_updated":"2026-07-30T18:01:40.268804-04:00"},"client":{"id":126906,"url":"https://lda.gov/api/v1/clients/126906/","client_id":12,"name":"JOHNSON & JOHNSON SERVICES INC","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"NJ","state_display":"New Jersey","country":"US","country_display":"United States of America","ppb_state":"NJ","ppb_state_display":"New Jersey","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-14"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"- H.R. 1539, Medical Device Electronic Labeling Act, regarding all provisions - H.R. 929/S. 266, the Dr. Lorna Breen Health Care Provider Protection Reauthorization Act, regarding all provisions - H.R. 946 ORPHAN Cures Act, regarding all provisions - S.864, HELP Copays Act, regarding all provisions - H.R. 2214, Delinking Revenue from Unfair Gouging (DRUG) Act, regarding all provisions - H.R. 1492/S. 832, Ensuring Pathways to Innovative Cures (EPIC) Act - S. 1954/ H.R. 5526 Biosimilar Red Tape Elimination Act, regarding all provisions - H.R.2527, Early Detection of Vision Impairments for Children Act of 2025, regarding all provisions - PL117-169 The Inflation Reduction Act, regarding all provisions related to drug pricing and implementation - H.R.5343/S. 1717, the Ensuring Patient Access to Critical Breakthrough Products Act of 2025, regarding all provisions - H.R.4282, Contact Lens Prescription Verification Modernization Act, regarding all provisions - H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act, regarding all provisions - S.1399 / H.R. 6197, the Health Tech Investment Act, regarding all provisions - H.R. 3521, the Clinical Trial Modernization Act, regarding all provisions - H.R. 3006 / S.1776, the Medicare Beneficiary Co-Pay Fairness Act, regarding all provisions - H.R. 3514, the Improving Seniors Timely Access to Care Act of 2025, regarding all provisions - H.R. 6549, the VA Contracting and Procurement Act, regarding all provisions - H.R. 5509 / S. 2903, Safe Step Act, regarding all provisions - H.R. 5256, 340B ACCESS Act, regarding all provisions - H.R. 7391, Community Health Center Drug Pricing Protection Act, regarding all provisions Issues related to - direct to consumer advertising - clinical trial modernization - biosimilars - cardiovascular health - 340B and 340B Rebate Pilot - Heart Recovery Awareness Day & H.Res. 1301, designating February 20th Heart Recovery Awareness Day - obesity treatments - MFN - Foreign Reference Pricing - CMS Outpatient Prospective Payment System rule - peripheral artery disease (PAD) - PBM and Insurer Reforms","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":91402,"prefix":null,"prefix_display":null,"first_name":"DEANA","nickname":null,"middle_name":null,"last_name":"MCRAE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70499,"prefix":null,"prefix_display":null,"first_name":"LEIF","nickname":null,"middle_name":null,"last_name":"BRIERLEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":71075,"prefix":null,"prefix_display":null,"first_name":"LARRY","nickname":null,"middle_name":null,"last_name":"CAMM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141363,"prefix":null,"prefix_display":null,"first_name":"TIMOTHY","nickname":null,"middle_name":null,"last_name":"SWOPE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":137136,"prefix":null,"prefix_display":null,"first_name":"WENDY","nickname":null,"middle_name":null,"last_name":"SUSSMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139147,"prefix":"mrs","prefix_display":"MRS.","first_name":"MEGHAN","nickname":null,"middle_name":"DRENAN","last_name":"STONE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":137135,"prefix":null,"prefix_display":null,"first_name":"AMY","nickname":null,"middle_name":null,"last_name":"PELLEGRINO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70494,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"WATERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":73113,"prefix":null,"prefix_display":null,"first_name":"ABIGAIL","nickname":null,"middle_name":null,"last_name":"PINKELE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":18909,"prefix":"mrs","prefix_display":"MRS.","first_name":"JANE","nickname":null,"middle_name":"MARGARET","last_name":"ADAMS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141364,"prefix":null,"prefix_display":null,"first_name":"COLLEEN","nickname":null,"middle_name":null,"last_name":"VIVALDI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":55206,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"KAVANAUGH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150724,"prefix":null,"prefix_display":null,"first_name":"JULIA","nickname":null,"middle_name":null,"last_name":"KALUSNIAK","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153683,"prefix":null,"prefix_display":null,"first_name":"JEFFREY","nickname":null,"middle_name":null,"last_name":"LAST","suffix":null,"suffix_display":null},"covered_position":"Sen. PA, Senate HELP Committee (2025); PA, Sen. Cornyn (2017-2022, 2023-2025); Sen. LA, Rep. Brady (2017); Sen. LA, Rep. Lance (2009-2012); LC/LA Rep. Knollenberg (2006-2008).","new":true},{"lobbyist":{"id":153684,"prefix":null,"prefix_display":null,"first_name":"FOLASHADE","nickname":null,"middle_name":null,"last_name":"WILSON","suffix":null,"suffix_display":null},"covered_position":"Health Fellow, Office of Robin Kelly (Sept 2024-Sept 2025); Health Fellow, Office of Bernard Sanders (Sept 2024-Oct 2025).","new":true},{"lobbyist":{"id":153685,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"CLARKIN","suffix":null,"suffix_display":null},"covered_position":"Legislative Director for Rep. Brian Fitzpatrick (March 2025-January 2026)","new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"- Issues related to stroke care","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":70499,"prefix":null,"prefix_display":null,"first_name":"LEIF","nickname":null,"middle_name":null,"last_name":"BRIERLEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"- S. 1040, Drug Competition Enhancement Act, regarding all provisions - S. 1041, Affordable Prescriptions for Patients Act of 2025, regarding all provisions - S. 1097, Interagency Patent Coordination and Improvement Act of 2025, regarding all provisions - H.R. 3269/S. 2276, Eliminating Thickets to Increase Competition (ETHIC) Act, regarding all provisions - S.2658, Medication Affordability and Patent Integrity Act Issues related to: - intellectual property, including amending the Federal Trade Commission Act to prohibit product hopping - patent thickets - patent fees","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":55206,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"KAVANAUGH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141363,"prefix":null,"prefix_display":null,"first_name":"TIMOTHY","nickname":null,"middle_name":null,"last_name":"SWOPE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":137136,"prefix":null,"prefix_display":null,"first_name":"WENDY","nickname":null,"middle_name":null,"last_name":"SUSSMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"LAW","general_issue_code_display":"Law Enforcement/Crime/Criminal Justice","description":"Issues related to - H.R. 1109, the Litigation Transparency Act of 2025, and transparency in domestic third-party litigation funding - H.R.2675, Protecting Our Courts from Foreign Manipulation Act, and transparency in foreign third-party litigation funding","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":18909,"prefix":"mrs","prefix_display":"MRS.","first_name":"JANE","nickname":null,"middle_name":"MARGARET","last_name":"ADAMS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70494,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"WATERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"- H.R. 2483, \"SUPPORT for Patients and Communities Reauthorization Act of 2025\", regarding all provisions.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":137135,"prefix":null,"prefix_display":null,"first_name":"AMY","nickname":null,"middle_name":null,"last_name":"PELLEGRINO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":137136,"prefix":null,"prefix_display":null,"first_name":"WENDY","nickname":null,"middle_name":null,"last_name":"SUSSMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"SCI","general_issue_code_display":"Science/Technology","description":"Issues related to - artificial intelligence - data privacy - cybersecurity - robotics","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":70499,"prefix":null,"prefix_display":null,"first_name":"LEIF","nickname":null,"middle_name":null,"last_name":"BRIERLEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Issues related to - OECD proposals on global tax & implementation and/or related Presidential executive orders - corporate tax provisions in OBBB and the corporate alternative minimum tax - use of excess pension funds","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":55206,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"KAVANAUGH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70494,"prefix":null,"prefix_display":null,"first_name":"KELLY","nickname":null,"middle_name":null,"last_name":"WATERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":41,"name":"Treasury, Dept of"}]},{"general_issue_code":"VET","general_issue_code_display":"Veterans","description":"Issues related to: - Veterans Administration and Veterans Health Administration procurement and contracting processes for medical technology - VA Program - military/veterans affairs health workforce and talent workforce","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":91402,"prefix":null,"prefix_display":null,"first_name":"DEANA","nickname":null,"middle_name":null,"last_name":"MCRAE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":137136,"prefix":null,"prefix_display":null,"first_name":"WENDY","nickname":null,"middle_name":null,"last_name":"SUSSMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70499,"prefix":null,"prefix_display":null,"first_name":"LEIF","nickname":null,"middle_name":null,"last_name":"BRIERLEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141364,"prefix":null,"prefix_display":null,"first_name":"COLLEEN","nickname":null,"middle_name":null,"last_name":"VIVALDI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":42,"name":"Veterans Affairs, Dept of (VA)"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"- Issues related to USMCA review and renegotiation","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":55206,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"KAVANAUGH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139147,"prefix":"mrs","prefix_display":"MRS.","first_name":"MEGHAN","nickname":null,"middle_name":"DRENAN","last_name":"STONE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":22,"name":"U.S. Trade Representative (USTR)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/8aa393f2-871b-412d-9e97-12ba492f642a/","filing_uuid":"8aa393f2-871b-412d-9e97-12ba492f642a","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/8aa393f2-871b-412d-9e97-12ba492f642a/print/","filing_document_content_type":"text/html","income":"9000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Laurie Bendall","dt_posted":"2026-04-20T16:49:21-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"300 New Jersey Ave, NW","registrant_address_2":"Suite 300","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":401103779,"url":"https://lda.gov/api/v1/registrants/401103779/","house_registrant_id":null,"name":"HIGH STREET STRATEGIES LLC","description":"private consulting firm","address_1":"300 New Jersey Ave, NW","address_2":"Suite 300","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MATT MULLIN","contact_telephone":"+1 202-900-9174","dt_updated":"2026-07-17T18:24:24.434069-04:00"},"client":{"id":60879,"url":"https://lda.gov/api/v1/clients/60879/","client_id":60879,"name":"AWESOME, INC.","general_description":"Parent company to several photography-based brands and web platforms","client_government_entity":null,"client_self_select":false,"state":"CA","state_display":"California","country":"US","country_display":"United States of America","ppb_state":"CA","ppb_state_display":"California","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2024-05-01"},"lobbying_activities":[{"general_issue_code":"ENV","general_issue_code_display":"Environment/Superfund","description":"Public Lands Protections Chuckwalla National Monument S. 1476/H.R. 2903 - M.H. Dutch Salmon Greater Gila Wild and Scenic River Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":62836,"prefix":null,"prefix_display":null,"first_name":"MATT","nickname":null,"middle_name":null,"last_name":"MULLIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139005,"prefix":"ms","prefix_display":"MS.","first_name":"NORAH","nickname":null,"middle_name":null,"last_name":"CARLOS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141867,"prefix":null,"prefix_display":null,"first_name":"ERIN","nickname":null,"middle_name":null,"last_name":"GAINES","suffix":null,"suffix_display":null},"covered_position":"Sen. Ron Wyden - Legislative Correspondent, Legislative Aide & Natural Resources Counsel; September 2013 - September 2017","new":false}],"government_entities":[{"id":53,"name":"Federal Communications Commission (FCC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TEC","general_issue_code_display":"Telecommunications","description":"Data privacy Section 230 S. 1586/H.R. 3149 - App Store Accountability Act H.R. 6333 - Parents Over Platforms Act Age verification Impacts of tech policy on middle-tech Kids Online Safety","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":62836,"prefix":null,"prefix_display":null,"first_name":"MATT","nickname":null,"middle_name":null,"last_name":"MULLIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141867,"prefix":null,"prefix_display":null,"first_name":"ERIN","nickname":null,"middle_name":null,"last_name":"GAINES","suffix":null,"suffix_display":null},"covered_position":"Sen. Ron Wyden - Legislative Correspondent, Legislative Aide & Natural Resources Counsel; September 2013 - September 2017","new":false},{"lobbyist":{"id":139005,"prefix":"ms","prefix_display":"MS.","first_name":"NORAH","nickname":null,"middle_name":null,"last_name":"CARLOS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/8ee51687-c53d-4bbb-ba32-36303b6c372e/","filing_uuid":"8ee51687-c53d-4bbb-ba32-36303b6c372e","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2026,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.gov/filings/public/filing/8ee51687-c53d-4bbb-ba32-36303b6c372e/print/","filing_document_content_type":"text/html","income":null,"expenses":"67545.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Brad Conway","dt_posted":"2026-04-23T09:55:04-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"11333 Woodglen Drive","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"North Bethesda","registrant_state":"MD","registrant_zip":"20852","registrant":{"id":1978,"url":"https://lda.gov/api/v1/registrants/1978/","house_registrant_id":31645,"name":"AMERICAN COLLEGE OF GASTROENTEROLOGY","description":null,"address_1":"11333 Woodglen Drive","address_2":null,"address_3":null,"address_4":null,"city":"North Bethesda","state":"MD","state_display":"Maryland","zip":"20852","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"BRAD CONWAY","contact_telephone":"+1 301-263-9000","dt_updated":"2026-07-16T15:36:11.061652-04:00"},"client":{"id":102671,"url":"https://lda.gov/api/v1/clients/102671/","client_id":12,"name":"AMERICAN COLLEGE OF GASTROENTEROLOGY","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"MD","state_display":"Maryland","country":"US","country_display":"United States of America","ppb_state":"MD","ppb_state_display":"Maryland","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-13"},"lobbying_activities":[{"general_issue_code":"INS","general_issue_code_display":"Insurance","description":"The Safe Step Act (H.R. 5509/S. 2093) requires group health plans regulated by the Employee Retirement Income Security Act (ERISA) to provide a clear exception process for any medication step therapy protocol.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":149169,"prefix":null,"prefix_display":null,"first_name":"BRAD","nickname":null,"middle_name":null,"last_name":"CONWAY","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":149170,"prefix":null,"prefix_display":null,"first_name":"ANGELICA","nickname":null,"middle_name":null,"last_name":"DUQUE","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Medicare physician reimbursement and the importance of long-term structural reform to the reimbursement system, including the Provider Reimbursement Stability Act (H.R. 8163), the Strengthening Medicare for Patients and Providers Act (H.R. 6160) and the Efficiency Adjustment Delay Act (H.R. 7520).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":149169,"prefix":null,"prefix_display":null,"first_name":"BRAD","nickname":null,"middle_name":null,"last_name":"CONWAY","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":149170,"prefix":null,"prefix_display":null,"first_name":"ANGELICA","nickname":null,"middle_name":null,"last_name":"DUQUE","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Medicare physician reimbursement and the importance of long-term structural reform to the reimbursement system, including the Provider Reimbursement Stability Act (H.R. 8163), the Strengthening Medicare for Patients and Providers Act (H.R. 6160) and the Efficiency Adjustment Delay Act (H.R. 7520) The Safe Step Act (H.R. 5509/S. 2903) requires group health plans regulated by the Employee Retirement Income Security Act (ERISA) to provide a clear exception process for any medication step therapy protocol. The Specialty Physicians Advancing Rural Care (SPARC) Act (S. 1380; H.R. 4681), a bill designed to increase access to specialty care services in rural areas. Expanding the definition of a preventive service to surveillance colonoscopy. Efforts to secure appropriations language that guides action at the U.S. Department of Health and Human Services. Opposing National Institutes of Health (NIH) research cuts.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":149169,"prefix":null,"prefix_display":null,"first_name":"BRAD","nickname":null,"middle_name":null,"last_name":"CONWAY","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":149170,"prefix":null,"prefix_display":null,"first_name":"ANGELICA","nickname":null,"middle_name":null,"last_name":"DUQUE","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Opposing National Institutes of Health (NIH) research cuts","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":149169,"prefix":null,"prefix_display":null,"first_name":"BRAD","nickname":null,"middle_name":null,"last_name":"CONWAY","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":149170,"prefix":null,"prefix_display":null,"first_name":"ANGELICA","nickname":null,"middle_name":null,"last_name":"DUQUE","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/df71bff2-9593-413e-ab5b-e6951d8bd77e/","filing_uuid":"df71bff2-9593-413e-ab5b-e6951d8bd77e","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/df71bff2-9593-413e-ab5b-e6951d8bd77e/print/","filing_document_content_type":"text/html","income":null,"expenses":"40000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Erin McKeon","dt_posted":"2026-07-07T10:37:28-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"733 Third Ave","registrant_address_2":"Suite 510","registrant_different_address":false,"registrant_city":"New York","registrant_state":"NY","registrant_zip":"10017","registrant":{"id":401105490,"url":"https://lda.gov/api/v1/registrants/401105490/","house_registrant_id":55808,"name":"CROHN'S & COLITIS FOUNDATION","description":null,"address_1":"733 Third Ave","address_2":"Suite 510","address_3":null,"address_4":null,"city":"New York","state":"NY","state_display":"New York","zip":"10017","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ERIN MCKEON","contact_telephone":"+1 202-210-1632","dt_updated":"2026-08-28T16:41:16.576715-04:00"},"client":{"id":55519,"url":"https://lda.gov/api/v1/clients/55519/","client_id":55519,"name":"CROHN'S & COLITIS FOUNDATION","general_description":"Nonprofit patient foundation.","client_government_entity":null,"client_self_select":true,"state":"NY","state_display":"New York","country":"US","country_display":"United States of America","ppb_state":"NY","ppb_state_display":"New York","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2023-01-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"FY 2027 Funding for medical research at the NIH and CDC FY 2027 Appropriations - DoD Congressionally Directed Medical Research Program S 864/ HR 6423 Help Ensure Lower Patient Copays Act S 526 Pharmacy Benefit Manager Transparency Act HR 5509/ S 2903: Safe Step Act S 3304 / HR 5684 Medical Foods and Formula Access Act CMS - Interoperability Standards and Prior Authorization for Drugs proposed rule CMS - RFI on step therapy in Medicare CMS - Reimbursement for infused biosimilars CMS - Medicare Competitive bidding for ostomy supplies FDA - Approvals for pediatric IBD medications HHS - FY 2027 NBPP","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":152894,"prefix":"ms","prefix_display":"MS.","first_name":"ERIN","nickname":null,"middle_name":"HENNESSEY","last_name":"MCKEON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/eb26a73f-56e5-41a1-bff5-8a92e5f22f8d/","filing_uuid":"eb26a73f-56e5-41a1-bff5-8a92e5f22f8d","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/eb26a73f-56e5-41a1-bff5-8a92e5f22f8d/print/","filing_document_content_type":"text/html","income":null,"expenses":"1240000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Adam Brand, Vice President, Government Affairs","dt_posted":"2026-07-16T08:19:36-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"2440 Research Drive","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Rockville","registrant_state":"MD","registrant_zip":"20850","registrant":{"id":401093052,"url":"https://lda.gov/api/v1/registrants/401093052/","house_registrant_id":null,"name":"OTSUKA AMERICA PHARMACEUTICAL, INC.","description":"Pharmaceutical research and development","address_1":"2440 Research Drive","address_2":null,"address_3":null,"address_4":null,"city":"Rockville","state":"MD","state_display":"Maryland","zip":"20850","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"AMELIA SUERMANN","contact_telephone":"+1 202-997-6592","dt_updated":"2026-07-28T09:37:13.144927-04:00"},"client":{"id":197760,"url":"https://lda.gov/api/v1/clients/197760/","client_id":12,"name":"OTSUKA AMERICA PHARMACEUTICAL, INC.","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"MD","state_display":"Maryland","country":"US","country_display":"United States of America","ppb_state":"MD","ppb_state_display":"Maryland","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2021-04-20"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Appropriations for the Department of Health & Human Services and the Department of Veterans Affairs, and Department of Defense.","foreign_entity_issues":"Otsuka (Japan), identified on filer's Registration Statement (LD-1), as its parent organization has an interest in the listed issues.","lobbyists":[{"lobbyist":{"id":147686,"prefix":null,"prefix_display":null,"first_name":"AMELIA","nickname":null,"middle_name":null,"last_name":"SUERMANN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152464,"prefix":null,"prefix_display":null,"first_name":"THOMAS","nickname":null,"middle_name":null,"last_name":"FOULKES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153427,"prefix":null,"prefix_display":null,"first_name":"ISABEL","nickname":null,"middle_name":null,"last_name":"OMER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"VET","general_issue_code_display":"Veterans","description":"Health care policies relating to mental health and PTSD, including authorizations and appropriations for the Department of Veterans Affairs related to mental health and PTSD.","foreign_entity_issues":"Otsuka (Japan), identified on filers Registration Statement (LD-1), as its parent organization has an interest in the listed issues.","lobbyists":[{"lobbyist":{"id":147686,"prefix":null,"prefix_display":null,"first_name":"AMELIA","nickname":null,"middle_name":null,"last_name":"SUERMANN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152464,"prefix":null,"prefix_display":null,"first_name":"THOMAS","nickname":null,"middle_name":null,"last_name":"FOULKES","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":153427,"prefix":null,"prefix_display":null,"first_name":"ISABEL","nickname":null,"middle_name":null,"last_name":"OMER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Implementation of the Inflation Reduction Act. Issues related to Medicare Part D redesign's impact on low-income subsidy beneficiaries. Issues related to prior authorization, open access, and medication step therapy; The Safe Step Act (HR 5509/S. 2903)","foreign_entity_issues":"Otsuka (Japan), identified on filer's Registration Statement (LD-1), as its parent organization has an interest in the listed issues.","lobbyists":[{"lobbyist":{"id":147686,"prefix":null,"prefix_display":null,"first_name":"AMELIA","nickname":null,"middle_name":null,"last_name":"SUERMANN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152464,"prefix":null,"prefix_display":null,"first_name":"THOMAS","nickname":null,"middle_name":null,"last_name":"FOULKES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153427,"prefix":null,"prefix_display":null,"first_name":"ISABEL","nickname":null,"middle_name":null,"last_name":"OMER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues relating to early detection of PTSD, mental health parity and coordinated care and mental health equity. PBM reform. Issues related to rare nephrology/kidney diseases, 340B reform, psychedelics treatments for PTSD and mental health. H.R. 1518, the New Era of Preventing End-Stage Kidney Disease Act. Issues related to drug pricing, foreign reference pricing, biomedical research, and pharmaceutical supply chain.","foreign_entity_issues":"Otsuka (Japan), identified on filer's Registration Statement (LD-1), as its parent organization has an interest in the listed issues.","lobbyists":[{"lobbyist":{"id":147686,"prefix":null,"prefix_display":null,"first_name":"AMELIA","nickname":null,"middle_name":null,"last_name":"SUERMANN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152464,"prefix":null,"prefix_display":null,"first_name":"THOMAS","nickname":null,"middle_name":null,"last_name":"FOULKES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153427,"prefix":null,"prefix_display":null,"first_name":"ISABEL","nickname":null,"middle_name":null,"last_name":"OMER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAR","general_issue_code_display":"Tariff (miscellaneous tariff bills)","description":"Issues related to tariffs on pharmaceuticals and pharmaceutical supply chain.","foreign_entity_issues":"Otsuka (Japan), identified on filers Registration Statement (LD-1), as its parent organization has an interest in the listed issues.","lobbyists":[{"lobbyist":{"id":147686,"prefix":null,"prefix_display":null,"first_name":"AMELIA","nickname":null,"middle_name":null,"last_name":"SUERMANN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152464,"prefix":null,"prefix_display":null,"first_name":"THOMAS","nickname":null,"middle_name":null,"last_name":"FOULKES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153427,"prefix":null,"prefix_display":null,"first_name":"ISABEL","nickname":null,"middle_name":null,"last_name":"OMER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/7c80590e-8829-41cf-a635-db969186403f/","filing_uuid":"7c80590e-8829-41cf-a635-db969186403f","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/7c80590e-8829-41cf-a635-db969186403f/print/","filing_document_content_type":"text/html","income":null,"expenses":"180000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Heather Strawn","dt_posted":"2026-07-16T11:11:51-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1455 Pennsylvania Ave NW","registrant_address_2":"Suite 400","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":400426042,"url":"https://lda.gov/api/v1/registrants/400426042/","house_registrant_id":null,"name":"LUNDBECK LLC","description":"Specialty and Central Nervous System Bio-pharmaceutical manufacturing","address_1":"1455 Pennsylvania Ave NW","address_2":"Suite 400","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"HEATHER STRAWN","contact_telephone":"+1 202-412-1563","dt_updated":"2026-07-29T13:14:27.156557-04:00"},"client":{"id":190625,"url":"https://lda.gov/api/v1/clients/190625/","client_id":12,"name":"LUNDBECK LLC","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2009-03-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues pertaining to the 340B Drug Discount Program - H.R. 5256, the 340B ACCESS Act; H.R.4581 & S. 2372, 340B PATIENTS Act of 2025; H.R. 9504, Tax Exempt Hospital Transparency Act Step therapy reform - H.R. 5509 & S. 2903, Safe Step Act Neuroscience Drug Program - FY 2026 and FY2027 AgFDA Appropriations BRAIN Initiative - FY 2026 and FY2027 Labor-HHS Appropriations Issues related to DTC advertising regulations Headache disorders treatment and research - H.R. 5536, HEADACHE Act of 2025 Research and services for epilepsy - H.R. 1189 & S. 494, National Plan for Epilepsy Act Issues pertaining to prior authorization - HR 9396, Prior Authorization Accountability Act Issues pertaining to transparency - HR 9393, Lower Costs, More Transparency Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":66159,"prefix":null,"prefix_display":null,"first_name":"HEATHER","nickname":null,"middle_name":null,"last_name":"STRAWN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143282,"prefix":null,"prefix_display":null,"first_name":"HAYLEY","nickname":null,"middle_name":null,"last_name":"ALEXANDER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153397,"prefix":null,"prefix_display":null,"first_name":"DARBIN","nickname":null,"middle_name":null,"last_name":"WOFFORD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152053,"prefix":null,"prefix_display":null,"first_name":"ZACHARY","nickname":null,"middle_name":null,"last_name":"POSS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues pertaining to the implementation of the Inflation Reduction Act of 2022 - H.R. 6166, Lowering Drug Costs for American Families Act Issues pertaining to CMS Coverage of APS in LTC Issues pertaining to Medicares Six Protected Classes policy Medicare Part D Smoothing Benefit - FY 2026 and FY2027 Labor-HHS Appropriations Orphan drug exclusion in the Inflation Reduction Act - H.R. 946 & S. 1862, ORPHAN Cures Act Small molecule discrepancy in the Inflation Reduction Act - H.R. 1492 & S. 832, The EPIC Act Issues pertaining to the Most Favored Nation drug price setting policy - H.R. 7837, Most Favored Patient Act of 2026 Issues pertaining to migraine screening for women in Medicare - FY 2026 and FY2027 Labor-HHS Appropriations Issues pertaining to prior authorization - HR 3514, Improving Seniors Timely Access to Care Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":66159,"prefix":null,"prefix_display":null,"first_name":"HEATHER","nickname":null,"middle_name":null,"last_name":"STRAWN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143282,"prefix":null,"prefix_display":null,"first_name":"HAYLEY","nickname":null,"middle_name":null,"last_name":"ALEXANDER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153397,"prefix":null,"prefix_display":null,"first_name":"DARBIN","nickname":null,"middle_name":null,"last_name":"WOFFORD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152053,"prefix":null,"prefix_display":null,"first_name":"ZACHARY","nickname":null,"middle_name":null,"last_name":"POSS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Tariffs on pharmaceutical products","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":66159,"prefix":null,"prefix_display":null,"first_name":"HEATHER","nickname":null,"middle_name":null,"last_name":"STRAWN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143282,"prefix":null,"prefix_display":null,"first_name":"HAYLEY","nickname":null,"middle_name":null,"last_name":"ALEXANDER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":153397,"prefix":null,"prefix_display":null,"first_name":"DARBIN","nickname":null,"middle_name":null,"last_name":"WOFFORD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152053,"prefix":null,"prefix_display":null,"first_name":"ZACHARY","nickname":null,"middle_name":null,"last_name":"POSS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/7aa7f5e1-1fd1-4cde-958e-be2195c5f5b8/","filing_uuid":"7aa7f5e1-1fd1-4cde-958e-be2195c5f5b8","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/7aa7f5e1-1fd1-4cde-958e-be2195c5f5b8/print/","filing_document_content_type":"text/html","income":null,"expenses":"240000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Christian Shalgian","dt_posted":"2026-07-16T11:29:43-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"20 F Street NW","registrant_address_2":"Suite 1000","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":45312,"url":"https://lda.gov/api/v1/registrants/45312/","house_registrant_id":34258,"name":"AMERICAN COLLEGE OF SURGEONS","description":"Lobbyist","address_1":"20 F Street NW","address_2":"Suite 1000","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"CHRISTIAN SHALGIAN","contact_telephone":"+1 202-337-2701","dt_updated":"2026-07-23T11:03:45.827465-04:00"},"client":{"id":153643,"url":"https://lda.gov/api/v1/clients/153643/","client_id":12,"name":"AMERICAN COLLEGE OF SURGEONS","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2008-04-14"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"H.R. 2433 - Reducing Medically Unnecessary Delays in Care Act of 2025 S. 266/H.R. 929 - Dr. Lorna Breen Healthcare Provider Protection Reauthorization Act S. 942/H.R. 2028 - Resident Education Deferred Interest (REDI) Act S. 1380 - Specialty Physicians Advancing Rural Care (SPARC) Act S. 2031 - Workforce Mobility Act S. 1595 - Improving Police Critical Aid for Responding to Emergencies (CARE) Act S. 1410 - Find it Early Act S. 1935 - Expanding Access to Palliative Care Act H.R. 2191 - Physician Led and Rural Access to Quality Care Act S. 106/H.R. 539 - Chiropractic Medicare Coverage Modernization Act of 2025 S.1816/H.R.3514 - Improving Seniors Timely Access to Care Act S. 4582/H.R. 7198 - Reintroduction of Ensuring Access to General Surgery Act H.R. 7520 - Efficiency Adjustment Delay Act H.R. 5509/S. 2903 - Safe Step Act H.R. 8358/S. 4318 - Breast Cancer Stamp Reauthorization Act Merit based Incentive Payment System (MIPS) Reform Value-Based Care (VBC) healthcare model CMS TEAM Model National Trauma and Emergency Preparedness System (NTEPS) RMOCC development Pre-hospital blood Medicare Economic Index (MEI) Indirect practice expense Medicare physician fee schedule CPT/Work Relative Value Units (RVUs) Tariffs on medical supplies Congressionally Directed Medical Research Programs Outpatient Prospective Payment System (OPPS) Ambulatory Surgical Center (ASC) Rule CollaboRATE Quality Measure WISeR Model Pandemic and All-Hazards Preparedness and Response Act (PAHPA) reauthorization National Institutes of Health Funding Global health funding Access to care issues One Big Beautiful Bill Act (Reconciliation) Congressionally Directed Medical Research Program (CDMRP) Veteran Healthcare Administration Confirmations Physician consolidation Medicare coding/payment for lower extremity revascularization services Medicare Physician Payment Cuts Neglected Surgical Conditions Administrative Burden/Prior Authorization Legislation MISSION Zero Reauthorization Bilateral Exchange Visa Issues/J-1 Visas for physician educational and cultural exchange Cancer Research Advocacy Agenda Trauma Advocacy Agenda Workforce Advocacy Agenda","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":28370,"prefix":null,"prefix_display":null,"first_name":"CHRISTIAN","nickname":null,"middle_name":null,"last_name":"SHALGIAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":51077,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"COFFRON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62433,"prefix":null,"prefix_display":null,"first_name":"CARRIE","nickname":null,"middle_name":null,"last_name":"ZLATOS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":102786,"prefix":null,"prefix_display":null,"first_name":"EMMA","nickname":null,"middle_name":null,"last_name":"ZIMMERMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147095,"prefix":"mrs","prefix_display":"MRS.","first_name":"COURTNEY","nickname":"EUBANKS","middle_name":null,"last_name":"LISOWSKI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145716,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"BROWN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147566,"prefix":null,"prefix_display":null,"first_name":"HALLIE","nickname":null,"middle_name":null,"last_name":"KOCH","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"H.R. 2433 - Reducing Medically Unnecessary Delays in Care Act of 2025 S. 266/H.R. 929 - Dr. Lorna Breen Healthcare Provider Protection Reauthorization Act S. 942/H.R. 2028 - Resident Education Deferred Interest (REDI) Act S. 1380 - Specialty Physicians Advancing Rural Care (SPARC) Act S. 2031 - Workforce Mobility Act S. 1595 - Improving Police Critical Aid for Responding to Emergencies (CARE) Act S. 1410 - Find it Early Act S. 1935 - Expanding Access to Palliative Care Act H.R. 2191 - Physician Led and Rural Access to Quality Care Act S. 106/H.R. 539 - Chiropractic Medicare Coverage Modernization Act of 2025 S.1816/H.R.3514 - Improving Seniors Timely Access to Care Act S. 4582/H.R. 7198 - Reintroduction of Ensuring Access to General Surgery Act H.R. 7520 - Efficiency Adjustment Delay Act H.R. 5509/S. 2903 - Safe Step Act H.R. 8358/S. 4318 - Breast Cancer Stamp Reauthorization Act Merit based Incentive Payment System (MIPS) Reform Value-Based Care (VBC) healthcare model CMS TEAM Model National Trauma and Emergency Preparedness System (NTEPS) RMOCC development Pre-hospital blood Medicare Economic Index (MEI) Indirect practice expense Medicare physician fee schedule CPT/Work Relative Value Units (RVUs) Tariffs on medical supplies Congressionally Directed Medical Research Programs Outpatient Prospective Payment System (OPPS) Ambulatory Surgical Center (ASC) Rule CollaboRATE Quality Measure WISeR Model Pandemic and All-Hazards Preparedness and Response Act (PAHPA) reauthorization National Institutes of Health Funding Global health funding Access to care issues One Big Beautiful Bill Act (Reconciliation) Congressionally Directed Medical Research Program (CDMRP) Veteran Healthcare Administration Confirmations Physician consolidation Medicare coding/payment for lower extremity revascularization services Medicare Physician Payment Cuts Neglected Surgical Conditions Administrative Burden/Prior Authorization Legislation MISSION Zero Reauthorization Bilateral Exchange Visa Issues/J-1 Visas for physician educational and cultural exchange Cancer Research Advocacy Agenda Trauma Advocacy Agenda Workforce Advocacy Agenda","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":145716,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"BROWN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147566,"prefix":null,"prefix_display":null,"first_name":"HALLIE","nickname":null,"middle_name":null,"last_name":"KOCH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":28370,"prefix":null,"prefix_display":null,"first_name":"CHRISTIAN","nickname":null,"middle_name":null,"last_name":"SHALGIAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":51077,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"COFFRON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62433,"prefix":null,"prefix_display":null,"first_name":"CARRIE","nickname":null,"middle_name":null,"last_name":"ZLATOS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":102786,"prefix":null,"prefix_display":null,"first_name":"EMMA","nickname":null,"middle_name":null,"last_name":"ZIMMERMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147095,"prefix":"mrs","prefix_display":"MRS.","first_name":"COURTNEY","nickname":"EUBANKS","middle_name":null,"last_name":"LISOWSKI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"National Institutes of Health Funding Cancer funding Government funding MISSION Zero Reauthorization One Big Beautiful Bill Act (Reconciliation) Budget neutrality FY27 Appropriations Rural health funding","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":28370,"prefix":null,"prefix_display":null,"first_name":"CHRISTIAN","nickname":null,"middle_name":null,"last_name":"SHALGIAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":51077,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"COFFRON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62433,"prefix":null,"prefix_display":null,"first_name":"CARRIE","nickname":null,"middle_name":null,"last_name":"ZLATOS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":102786,"prefix":null,"prefix_display":null,"first_name":"EMMA","nickname":null,"middle_name":null,"last_name":"ZIMMERMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147095,"prefix":"mrs","prefix_display":"MRS.","first_name":"COURTNEY","nickname":"EUBANKS","middle_name":null,"last_name":"LISOWSKI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145716,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"BROWN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147566,"prefix":null,"prefix_display":null,"first_name":"HALLIE","nickname":null,"middle_name":null,"last_name":"KOCH","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"VET","general_issue_code_display":"Veterans","description":"Dept of VA Cancer Database Veteran Healthcare","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":28370,"prefix":null,"prefix_display":null,"first_name":"CHRISTIAN","nickname":null,"middle_name":null,"last_name":"SHALGIAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":51077,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"COFFRON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62433,"prefix":null,"prefix_display":null,"first_name":"CARRIE","nickname":null,"middle_name":null,"last_name":"ZLATOS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":102786,"prefix":null,"prefix_display":null,"first_name":"EMMA","nickname":null,"middle_name":null,"last_name":"ZIMMERMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147095,"prefix":"mrs","prefix_display":"MRS.","first_name":"COURTNEY","nickname":"EUBANKS","middle_name":null,"last_name":"LISOWSKI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145716,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"BROWN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147566,"prefix":null,"prefix_display":null,"first_name":"HALLIE","nickname":null,"middle_name":null,"last_name":"KOCH","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":42,"name":"Veterans Affairs, Dept of (VA)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/7aa7f5e1-1fd1-4cde-958e-be2195c5f5b8/","filing_uuid":"7aa7f5e1-1fd1-4cde-958e-be2195c5f5b8","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/7aa7f5e1-1fd1-4cde-958e-be2195c5f5b8/print/","filing_document_content_type":"text/html","income":null,"expenses":"240000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Christian Shalgian","dt_posted":"2026-07-16T11:29:43-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"20 F Street NW","registrant_address_2":"Suite 1000","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":45312,"url":"https://lda.gov/api/v1/registrants/45312/","house_registrant_id":34258,"name":"AMERICAN COLLEGE OF SURGEONS","description":"Lobbyist","address_1":"20 F Street NW","address_2":"Suite 1000","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"CHRISTIAN SHALGIAN","contact_telephone":"+1 202-337-2701","dt_updated":"2026-07-23T11:03:45.827465-04:00"},"client":{"id":153643,"url":"https://lda.gov/api/v1/clients/153643/","client_id":12,"name":"AMERICAN COLLEGE OF SURGEONS","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2008-04-14"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"H.R. 2433 - Reducing Medically Unnecessary Delays in Care Act of 2025 S. 266/H.R. 929 - Dr. Lorna Breen Healthcare Provider Protection Reauthorization Act S. 942/H.R. 2028 - Resident Education Deferred Interest (REDI) Act S. 1380 - Specialty Physicians Advancing Rural Care (SPARC) Act S. 2031 - Workforce Mobility Act S. 1595 - Improving Police Critical Aid for Responding to Emergencies (CARE) Act S. 1410 - Find it Early Act S. 1935 - Expanding Access to Palliative Care Act H.R. 2191 - Physician Led and Rural Access to Quality Care Act S. 106/H.R. 539 - Chiropractic Medicare Coverage Modernization Act of 2025 S.1816/H.R.3514 - Improving Seniors Timely Access to Care Act S. 4582/H.R. 7198 - Reintroduction of Ensuring Access to General Surgery Act H.R. 7520 - Efficiency Adjustment Delay Act H.R. 5509/S. 2903 - Safe Step Act H.R. 8358/S. 4318 - Breast Cancer Stamp Reauthorization Act Merit based Incentive Payment System (MIPS) Reform Value-Based Care (VBC) healthcare model CMS TEAM Model National Trauma and Emergency Preparedness System (NTEPS) RMOCC development Pre-hospital blood Medicare Economic Index (MEI) Indirect practice expense Medicare physician fee schedule CPT/Work Relative Value Units (RVUs) Tariffs on medical supplies Congressionally Directed Medical Research Programs Outpatient Prospective Payment System (OPPS) Ambulatory Surgical Center (ASC) Rule CollaboRATE Quality Measure WISeR Model Pandemic and All-Hazards Preparedness and Response Act (PAHPA) reauthorization National Institutes of Health Funding Global health funding Access to care issues One Big Beautiful Bill Act (Reconciliation) Congressionally Directed Medical Research Program (CDMRP) Veteran Healthcare Administration Confirmations Physician consolidation Medicare coding/payment for lower extremity revascularization services Medicare Physician Payment Cuts Neglected Surgical Conditions Administrative Burden/Prior Authorization Legislation MISSION Zero Reauthorization Bilateral Exchange Visa Issues/J-1 Visas for physician educational and cultural exchange Cancer Research Advocacy Agenda Trauma Advocacy Agenda Workforce Advocacy Agenda","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":28370,"prefix":null,"prefix_display":null,"first_name":"CHRISTIAN","nickname":null,"middle_name":null,"last_name":"SHALGIAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":51077,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"COFFRON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62433,"prefix":null,"prefix_display":null,"first_name":"CARRIE","nickname":null,"middle_name":null,"last_name":"ZLATOS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":102786,"prefix":null,"prefix_display":null,"first_name":"EMMA","nickname":null,"middle_name":null,"last_name":"ZIMMERMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147095,"prefix":"mrs","prefix_display":"MRS.","first_name":"COURTNEY","nickname":"EUBANKS","middle_name":null,"last_name":"LISOWSKI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145716,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"BROWN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147566,"prefix":null,"prefix_display":null,"first_name":"HALLIE","nickname":null,"middle_name":null,"last_name":"KOCH","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"H.R. 2433 - Reducing Medically Unnecessary Delays in Care Act of 2025 S. 266/H.R. 929 - Dr. Lorna Breen Healthcare Provider Protection Reauthorization Act S. 942/H.R. 2028 - Resident Education Deferred Interest (REDI) Act S. 1380 - Specialty Physicians Advancing Rural Care (SPARC) Act S. 2031 - Workforce Mobility Act S. 1595 - Improving Police Critical Aid for Responding to Emergencies (CARE) Act S. 1410 - Find it Early Act S. 1935 - Expanding Access to Palliative Care Act H.R. 2191 - Physician Led and Rural Access to Quality Care Act S. 106/H.R. 539 - Chiropractic Medicare Coverage Modernization Act of 2025 S.1816/H.R.3514 - Improving Seniors Timely Access to Care Act S. 4582/H.R. 7198 - Reintroduction of Ensuring Access to General Surgery Act H.R. 7520 - Efficiency Adjustment Delay Act H.R. 5509/S. 2903 - Safe Step Act H.R. 8358/S. 4318 - Breast Cancer Stamp Reauthorization Act Merit based Incentive Payment System (MIPS) Reform Value-Based Care (VBC) healthcare model CMS TEAM Model National Trauma and Emergency Preparedness System (NTEPS) RMOCC development Pre-hospital blood Medicare Economic Index (MEI) Indirect practice expense Medicare physician fee schedule CPT/Work Relative Value Units (RVUs) Tariffs on medical supplies Congressionally Directed Medical Research Programs Outpatient Prospective Payment System (OPPS) Ambulatory Surgical Center (ASC) Rule CollaboRATE Quality Measure WISeR Model Pandemic and All-Hazards Preparedness and Response Act (PAHPA) reauthorization National Institutes of Health Funding Global health funding Access to care issues One Big Beautiful Bill Act (Reconciliation) Congressionally Directed Medical Research Program (CDMRP) Veteran Healthcare Administration Confirmations Physician consolidation Medicare coding/payment for lower extremity revascularization services Medicare Physician Payment Cuts Neglected Surgical Conditions Administrative Burden/Prior Authorization Legislation MISSION Zero Reauthorization Bilateral Exchange Visa Issues/J-1 Visas for physician educational and cultural exchange Cancer Research Advocacy Agenda Trauma Advocacy Agenda Workforce Advocacy Agenda","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":145716,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"BROWN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147566,"prefix":null,"prefix_display":null,"first_name":"HALLIE","nickname":null,"middle_name":null,"last_name":"KOCH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":28370,"prefix":null,"prefix_display":null,"first_name":"CHRISTIAN","nickname":null,"middle_name":null,"last_name":"SHALGIAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":51077,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"COFFRON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62433,"prefix":null,"prefix_display":null,"first_name":"CARRIE","nickname":null,"middle_name":null,"last_name":"ZLATOS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":102786,"prefix":null,"prefix_display":null,"first_name":"EMMA","nickname":null,"middle_name":null,"last_name":"ZIMMERMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147095,"prefix":"mrs","prefix_display":"MRS.","first_name":"COURTNEY","nickname":"EUBANKS","middle_name":null,"last_name":"LISOWSKI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"National Institutes of Health Funding Cancer funding Government funding MISSION Zero Reauthorization One Big Beautiful Bill Act (Reconciliation) Budget neutrality FY27 Appropriations Rural health funding","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":28370,"prefix":null,"prefix_display":null,"first_name":"CHRISTIAN","nickname":null,"middle_name":null,"last_name":"SHALGIAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":51077,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"COFFRON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62433,"prefix":null,"prefix_display":null,"first_name":"CARRIE","nickname":null,"middle_name":null,"last_name":"ZLATOS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":102786,"prefix":null,"prefix_display":null,"first_name":"EMMA","nickname":null,"middle_name":null,"last_name":"ZIMMERMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147095,"prefix":"mrs","prefix_display":"MRS.","first_name":"COURTNEY","nickname":"EUBANKS","middle_name":null,"last_name":"LISOWSKI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145716,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"BROWN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147566,"prefix":null,"prefix_display":null,"first_name":"HALLIE","nickname":null,"middle_name":null,"last_name":"KOCH","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"VET","general_issue_code_display":"Veterans","description":"Dept of VA Cancer Database Veteran Healthcare","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":28370,"prefix":null,"prefix_display":null,"first_name":"CHRISTIAN","nickname":null,"middle_name":null,"last_name":"SHALGIAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":51077,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"COFFRON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62433,"prefix":null,"prefix_display":null,"first_name":"CARRIE","nickname":null,"middle_name":null,"last_name":"ZLATOS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":102786,"prefix":null,"prefix_display":null,"first_name":"EMMA","nickname":null,"middle_name":null,"last_name":"ZIMMERMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147095,"prefix":"mrs","prefix_display":"MRS.","first_name":"COURTNEY","nickname":"EUBANKS","middle_name":null,"last_name":"LISOWSKI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145716,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"BROWN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147566,"prefix":null,"prefix_display":null,"first_name":"HALLIE","nickname":null,"middle_name":null,"last_name":"KOCH","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":42,"name":"Veterans Affairs, Dept of (VA)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/78051605-5336-4294-8d5f-0429627a6b0a/","filing_uuid":"78051605-5336-4294-8d5f-0429627a6b0a","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/78051605-5336-4294-8d5f-0429627a6b0a/print/","filing_document_content_type":"text/html","income":null,"expenses":"30000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Christian Shalgian","dt_posted":"2026-07-16T11:35:31-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"20 F STREET NW","registrant_address_2":"SUITE 1000","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":91251,"url":"https://lda.gov/api/v1/registrants/91251/","house_registrant_id":36362,"name":"AMERICAN COLLEGE OF SURGEONS PROFESSIONAL ASSOCIATION","description":null,"address_1":"20 F STREET NW","address_2":"SUITE 1000","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"CHRISTIAN SHALGIAN","contact_telephone":"+1 202-337-2701","dt_updated":"2026-07-23T11:13:45.913094-04:00"},"client":{"id":174581,"url":"https://lda.gov/api/v1/clients/174581/","client_id":12,"name":"AMERICAN COLLEGE OF SURGEONS PROFESSIONAL ASSOCIATION","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-02"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"H.R. 2433 - Reducing Medically Unnecessary Delays in Care Act of 2025 S. 266/H.R. 929 - Dr. Lorna Breen Healthcare Provider Protection Reauthorization Act S. 942/H.R. 2028 - Resident Education Deferred Interest (REDI) Act S. 1380 - Specialty Physicians Advancing Rural Care (SPARC) Act S. 2031 - Workforce Mobility Act S. 1595 - Improving Police Critical Aid for Responding to Emergencies (CARE) Act S. 1410 - Find it Early Act S. 1935 - Expanding Access to Palliative Care Act H.R. 2191 - Physician Led and Rural Access to Quality Care Act S. 106/H.R. 539 - Chiropractic Medicare Coverage Modernization Act of 2025 S.1816/H.R.3514 - Improving Seniors Timely Access to Care Act S. 4582/H.R. 7198 - Reintroduction of Ensuring Access to General Surgery Act H.R. 7520 - Efficiency Adjustment Delay Act H.R. 5509/S. 2903 - Safe Step Act H.R. 8358/S. 4318 - Breast Cancer Stamp Reauthorization Act Merit based Incentive Payment System (MIPS) Reform Value-Based Care (VBC) healthcare model CMS TEAM Model National Trauma and Emergency Preparedness System (NTEPS) RMOCC development Pre-hospital blood Medicare Economic Index (MEI) Indirect practice expense Medicare physician fee schedule CPT/Work Relative Value Units (RVUs) Tariffs on medical supplies Congressionally Directed Medical Research Programs Outpatient Prospective Payment System (OPPS) Ambulatory Surgical Center (ASC) Rule CollaboRATE Quality Measure WISeR Model Pandemic and All-Hazards Preparedness and Response Act (PAHPA) reauthorization National Institutes of Health Funding Global health funding Access to care issues One Big Beautiful Bill Act (Reconciliation) Congressionally Directed Medical Research Program (CDMRP) Veteran Healthcare Administration Confirmations Physician consolidation Medicare coding/payment for lower extremity revascularization services Medicare Physician Payment Cuts Neglected Surgical Conditions Administrative Burden/Prior Authorization Legislation MISSION Zero Reauthorization Bilateral Exchange Visa Issues/J-1 Visas for physician educational and cultural exchange Cancer Research Advocacy Agenda Trauma Advocacy Agenda Workforce Advocacy Agenda","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147568,"prefix":null,"prefix_display":null,"first_name":"HALLIE","nickname":null,"middle_name":null,"last_name":"KOCH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":13728,"prefix":null,"prefix_display":null,"first_name":"CHRISTIAN","nickname":null,"middle_name":null,"last_name":"SHALGIAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":51081,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"COFFRON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62439,"prefix":null,"prefix_display":null,"first_name":"CARRIE","nickname":null,"middle_name":null,"last_name":"ZLATOS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":102807,"prefix":null,"prefix_display":null,"first_name":"EMMA","nickname":null,"middle_name":null,"last_name":"ZIMMERMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147567,"prefix":null,"prefix_display":null,"first_name":"COURTNEY","nickname":null,"middle_name":null,"last_name":"EUBANKS LISOWSKI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145717,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"BROWN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"H.R. 2433 - Reducing Medically Unnecessary Delays in Care Act of 2025 S. 266/H.R. 929 - Dr. Lorna Breen Healthcare Provider Protection Reauthorization Act S. 942/H.R. 2028 - Resident Education Deferred Interest (REDI) Act S. 1380 - Specialty Physicians Advancing Rural Care (SPARC) Act S. 2031 - Workforce Mobility Act S. 1595 - Improving Police Critical Aid for Responding to Emergencies (CARE) Act S. 1410 - Find it Early Act S. 1935 - Expanding Access to Palliative Care Act H.R. 2191 - Physician Led and Rural Access to Quality Care Act S. 106/H.R. 539 - Chiropractic Medicare Coverage Modernization Act of 2025 S.1816/H.R.3514 - Improving Seniors Timely Access to Care Act S. 4582/H.R. 7198 - Reintroduction of Ensuring Access to General Surgery Act H.R. 7520 - Efficiency Adjustment Delay Act H.R. 5509/S. 2903 - Safe Step Act H.R. 8358/S. 4318 - Breast Cancer Stamp Reauthorization Act Merit based Incentive Payment System (MIPS) Reform Value-Based Care (VBC) healthcare model CMS TEAM Model National Trauma and Emergency Preparedness System (NTEPS) RMOCC development Pre-hospital blood Medicare Economic Index (MEI) Indirect practice expense Medicare physician fee schedule CPT/Work Relative Value Units (RVUs) Tariffs on medical supplies Congressionally Directed Medical Research Programs Outpatient Prospective Payment System (OPPS) Ambulatory Surgical Center (ASC) Rule CollaboRATE Quality Measure WISeR Model Pandemic and All-Hazards Preparedness and Response Act (PAHPA) reauthorization National Institutes of Health Funding Global health funding Access to care issues One Big Beautiful Bill Act (Reconciliation) Congressionally Directed Medical Research Program (CDMRP) Veteran Healthcare Administration Confirmations Physician consolidation Medicare coding/payment for lower extremity revascularization services Medicare Physician Payment Cuts Neglected Surgical Conditions Administrative Burden/Prior Authorization Legislation MISSION Zero Reauthorization Bilateral Exchange Visa Issues/J-1 Visas for physician educational and cultural exchange Cancer Research Advocacy Agenda Trauma Advocacy Agenda Workforce Advocacy Agenda","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":13728,"prefix":null,"prefix_display":null,"first_name":"CHRISTIAN","nickname":null,"middle_name":null,"last_name":"SHALGIAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":51081,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"COFFRON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62439,"prefix":null,"prefix_display":null,"first_name":"CARRIE","nickname":null,"middle_name":null,"last_name":"ZLATOS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":102807,"prefix":null,"prefix_display":null,"first_name":"EMMA","nickname":null,"middle_name":null,"last_name":"ZIMMERMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147567,"prefix":null,"prefix_display":null,"first_name":"COURTNEY","nickname":null,"middle_name":null,"last_name":"EUBANKS LISOWSKI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145717,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"BROWN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147568,"prefix":null,"prefix_display":null,"first_name":"HALLIE","nickname":null,"middle_name":null,"last_name":"KOCH","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"National Institutes of Health Funding Cancer funding Government funding MISSION Zero Reauthorization One Big Beautiful Bill Act (Reconciliation) Budget neutrality FY27 Appropriations Rural health funding","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147568,"prefix":null,"prefix_display":null,"first_name":"HALLIE","nickname":null,"middle_name":null,"last_name":"KOCH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":13728,"prefix":null,"prefix_display":null,"first_name":"CHRISTIAN","nickname":null,"middle_name":null,"last_name":"SHALGIAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":51081,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"COFFRON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62439,"prefix":null,"prefix_display":null,"first_name":"CARRIE","nickname":null,"middle_name":null,"last_name":"ZLATOS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":102807,"prefix":null,"prefix_display":null,"first_name":"EMMA","nickname":null,"middle_name":null,"last_name":"ZIMMERMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147567,"prefix":null,"prefix_display":null,"first_name":"COURTNEY","nickname":null,"middle_name":null,"last_name":"EUBANKS LISOWSKI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145717,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"BROWN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"VET","general_issue_code_display":"Veterans","description":"Dept of VA Cancer Database Veteran Healthcare","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":13728,"prefix":null,"prefix_display":null,"first_name":"CHRISTIAN","nickname":null,"middle_name":null,"last_name":"SHALGIAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":51081,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"COFFRON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62439,"prefix":null,"prefix_display":null,"first_name":"CARRIE","nickname":null,"middle_name":null,"last_name":"ZLATOS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":102807,"prefix":null,"prefix_display":null,"first_name":"EMMA","nickname":null,"middle_name":null,"last_name":"ZIMMERMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147567,"prefix":null,"prefix_display":null,"first_name":"COURTNEY","nickname":null,"middle_name":null,"last_name":"EUBANKS LISOWSKI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145717,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"BROWN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147568,"prefix":null,"prefix_display":null,"first_name":"HALLIE","nickname":null,"middle_name":null,"last_name":"KOCH","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":42,"name":"Veterans Affairs, Dept of (VA)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/78051605-5336-4294-8d5f-0429627a6b0a/","filing_uuid":"78051605-5336-4294-8d5f-0429627a6b0a","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/78051605-5336-4294-8d5f-0429627a6b0a/print/","filing_document_content_type":"text/html","income":null,"expenses":"30000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Christian Shalgian","dt_posted":"2026-07-16T11:35:31-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"20 F STREET NW","registrant_address_2":"SUITE 1000","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":91251,"url":"https://lda.gov/api/v1/registrants/91251/","house_registrant_id":36362,"name":"AMERICAN COLLEGE OF SURGEONS PROFESSIONAL ASSOCIATION","description":null,"address_1":"20 F STREET NW","address_2":"SUITE 1000","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"CHRISTIAN SHALGIAN","contact_telephone":"+1 202-337-2701","dt_updated":"2026-07-23T11:13:45.913094-04:00"},"client":{"id":174581,"url":"https://lda.gov/api/v1/clients/174581/","client_id":12,"name":"AMERICAN COLLEGE OF SURGEONS PROFESSIONAL ASSOCIATION","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-02"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"H.R. 2433 - Reducing Medically Unnecessary Delays in Care Act of 2025 S. 266/H.R. 929 - Dr. Lorna Breen Healthcare Provider Protection Reauthorization Act S. 942/H.R. 2028 - Resident Education Deferred Interest (REDI) Act S. 1380 - Specialty Physicians Advancing Rural Care (SPARC) Act S. 2031 - Workforce Mobility Act S. 1595 - Improving Police Critical Aid for Responding to Emergencies (CARE) Act S. 1410 - Find it Early Act S. 1935 - Expanding Access to Palliative Care Act H.R. 2191 - Physician Led and Rural Access to Quality Care Act S. 106/H.R. 539 - Chiropractic Medicare Coverage Modernization Act of 2025 S.1816/H.R.3514 - Improving Seniors Timely Access to Care Act S. 4582/H.R. 7198 - Reintroduction of Ensuring Access to General Surgery Act H.R. 7520 - Efficiency Adjustment Delay Act H.R. 5509/S. 2903 - Safe Step Act H.R. 8358/S. 4318 - Breast Cancer Stamp Reauthorization Act Merit based Incentive Payment System (MIPS) Reform Value-Based Care (VBC) healthcare model CMS TEAM Model National Trauma and Emergency Preparedness System (NTEPS) RMOCC development Pre-hospital blood Medicare Economic Index (MEI) Indirect practice expense Medicare physician fee schedule CPT/Work Relative Value Units (RVUs) Tariffs on medical supplies Congressionally Directed Medical Research Programs Outpatient Prospective Payment System (OPPS) Ambulatory Surgical Center (ASC) Rule CollaboRATE Quality Measure WISeR Model Pandemic and All-Hazards Preparedness and Response Act (PAHPA) reauthorization National Institutes of Health Funding Global health funding Access to care issues One Big Beautiful Bill Act (Reconciliation) Congressionally Directed Medical Research Program (CDMRP) Veteran Healthcare Administration Confirmations Physician consolidation Medicare coding/payment for lower extremity revascularization services Medicare Physician Payment Cuts Neglected Surgical Conditions Administrative Burden/Prior Authorization Legislation MISSION Zero Reauthorization Bilateral Exchange Visa Issues/J-1 Visas for physician educational and cultural exchange Cancer Research Advocacy Agenda Trauma Advocacy Agenda Workforce Advocacy Agenda","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147568,"prefix":null,"prefix_display":null,"first_name":"HALLIE","nickname":null,"middle_name":null,"last_name":"KOCH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":13728,"prefix":null,"prefix_display":null,"first_name":"CHRISTIAN","nickname":null,"middle_name":null,"last_name":"SHALGIAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":51081,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"COFFRON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62439,"prefix":null,"prefix_display":null,"first_name":"CARRIE","nickname":null,"middle_name":null,"last_name":"ZLATOS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":102807,"prefix":null,"prefix_display":null,"first_name":"EMMA","nickname":null,"middle_name":null,"last_name":"ZIMMERMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147567,"prefix":null,"prefix_display":null,"first_name":"COURTNEY","nickname":null,"middle_name":null,"last_name":"EUBANKS LISOWSKI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145717,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"BROWN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"H.R. 2433 - Reducing Medically Unnecessary Delays in Care Act of 2025 S. 266/H.R. 929 - Dr. Lorna Breen Healthcare Provider Protection Reauthorization Act S. 942/H.R. 2028 - Resident Education Deferred Interest (REDI) Act S. 1380 - Specialty Physicians Advancing Rural Care (SPARC) Act S. 2031 - Workforce Mobility Act S. 1595 - Improving Police Critical Aid for Responding to Emergencies (CARE) Act S. 1410 - Find it Early Act S. 1935 - Expanding Access to Palliative Care Act H.R. 2191 - Physician Led and Rural Access to Quality Care Act S. 106/H.R. 539 - Chiropractic Medicare Coverage Modernization Act of 2025 S.1816/H.R.3514 - Improving Seniors Timely Access to Care Act S. 4582/H.R. 7198 - Reintroduction of Ensuring Access to General Surgery Act H.R. 7520 - Efficiency Adjustment Delay Act H.R. 5509/S. 2903 - Safe Step Act H.R. 8358/S. 4318 - Breast Cancer Stamp Reauthorization Act Merit based Incentive Payment System (MIPS) Reform Value-Based Care (VBC) healthcare model CMS TEAM Model National Trauma and Emergency Preparedness System (NTEPS) RMOCC development Pre-hospital blood Medicare Economic Index (MEI) Indirect practice expense Medicare physician fee schedule CPT/Work Relative Value Units (RVUs) Tariffs on medical supplies Congressionally Directed Medical Research Programs Outpatient Prospective Payment System (OPPS) Ambulatory Surgical Center (ASC) Rule CollaboRATE Quality Measure WISeR Model Pandemic and All-Hazards Preparedness and Response Act (PAHPA) reauthorization National Institutes of Health Funding Global health funding Access to care issues One Big Beautiful Bill Act (Reconciliation) Congressionally Directed Medical Research Program (CDMRP) Veteran Healthcare Administration Confirmations Physician consolidation Medicare coding/payment for lower extremity revascularization services Medicare Physician Payment Cuts Neglected Surgical Conditions Administrative Burden/Prior Authorization Legislation MISSION Zero Reauthorization Bilateral Exchange Visa Issues/J-1 Visas for physician educational and cultural exchange Cancer Research Advocacy Agenda Trauma Advocacy Agenda Workforce Advocacy Agenda","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":13728,"prefix":null,"prefix_display":null,"first_name":"CHRISTIAN","nickname":null,"middle_name":null,"last_name":"SHALGIAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":51081,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"COFFRON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62439,"prefix":null,"prefix_display":null,"first_name":"CARRIE","nickname":null,"middle_name":null,"last_name":"ZLATOS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":102807,"prefix":null,"prefix_display":null,"first_name":"EMMA","nickname":null,"middle_name":null,"last_name":"ZIMMERMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147567,"prefix":null,"prefix_display":null,"first_name":"COURTNEY","nickname":null,"middle_name":null,"last_name":"EUBANKS LISOWSKI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145717,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"BROWN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147568,"prefix":null,"prefix_display":null,"first_name":"HALLIE","nickname":null,"middle_name":null,"last_name":"KOCH","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"National Institutes of Health Funding Cancer funding Government funding MISSION Zero Reauthorization One Big Beautiful Bill Act (Reconciliation) Budget neutrality FY27 Appropriations Rural health funding","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147568,"prefix":null,"prefix_display":null,"first_name":"HALLIE","nickname":null,"middle_name":null,"last_name":"KOCH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":13728,"prefix":null,"prefix_display":null,"first_name":"CHRISTIAN","nickname":null,"middle_name":null,"last_name":"SHALGIAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":51081,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"COFFRON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62439,"prefix":null,"prefix_display":null,"first_name":"CARRIE","nickname":null,"middle_name":null,"last_name":"ZLATOS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":102807,"prefix":null,"prefix_display":null,"first_name":"EMMA","nickname":null,"middle_name":null,"last_name":"ZIMMERMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147567,"prefix":null,"prefix_display":null,"first_name":"COURTNEY","nickname":null,"middle_name":null,"last_name":"EUBANKS LISOWSKI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145717,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"BROWN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"VET","general_issue_code_display":"Veterans","description":"Dept of VA Cancer Database Veteran Healthcare","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":13728,"prefix":null,"prefix_display":null,"first_name":"CHRISTIAN","nickname":null,"middle_name":null,"last_name":"SHALGIAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":51081,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"COFFRON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":62439,"prefix":null,"prefix_display":null,"first_name":"CARRIE","nickname":null,"middle_name":null,"last_name":"ZLATOS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":102807,"prefix":null,"prefix_display":null,"first_name":"EMMA","nickname":null,"middle_name":null,"last_name":"ZIMMERMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147567,"prefix":null,"prefix_display":null,"first_name":"COURTNEY","nickname":null,"middle_name":null,"last_name":"EUBANKS LISOWSKI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145717,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"BROWN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147568,"prefix":null,"prefix_display":null,"first_name":"HALLIE","nickname":null,"middle_name":null,"last_name":"KOCH","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":42,"name":"Veterans Affairs, Dept of (VA)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/d48a3371-625d-45d4-a725-d1e8ea0d7d00/","filing_uuid":"d48a3371-625d-45d4-a725-d1e8ea0d7d00","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/d48a3371-625d-45d4-a725-d1e8ea0d7d00/print/","filing_document_content_type":"text/html","income":null,"expenses":"480000.00","expenses_method":"B","expenses_method_display":"B","posted_by_name":"Kristine Rufener","dt_posted":"2026-07-16T11:38:53-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"2318 Mill Rd","registrant_address_2":"Suite 800","registrant_different_address":false,"registrant_city":"Alexandria","registrant_state":"VA","registrant_zip":"22314","registrant":{"id":401105592,"url":"https://lda.gov/api/v1/registrants/401105592/","house_registrant_id":null,"name":"ASSOCIATION FOR CLINICAL ONCOLOGY","description":"physician medical specialty society","address_1":"2318 Mill Rd","address_2":"Suite 800","address_3":null,"address_4":null,"city":"Alexandria","state":"VA","state_display":"Virginia","zip":"22314","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ANTHONY PEREZ","contact_telephone":"+1 571-483-1496","dt_updated":"2026-07-21T14:12:19.395401-04:00"},"client":{"id":205751,"url":"https://lda.gov/api/v1/clients/205751/","client_id":12,"name":"ASSOCIATION FOR CLINICAL ONCOLOGY","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"VA","state_display":"Virginia","country":"US","country_display":"United States of America","ppb_state":"VA","ppb_state_display":"Virginia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2020-01-01"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"H.R. 3514/S. 1816: Improving Seniors' Timely Access to Care Act of 2025 - requires Medicare Advantage plans to implement electronic prior authorization, increase transparency, protect enrollees, and adhere to new response timeframes to improve timely access to care. H.R. 2433: Reducing Medically Unnecessary Delays in Care Act - mandates that prior authorization decisions under Medicare be made by qualified physicians, based on medical necessity and evidence-based standards, with transparency and input from practicing physicians. S. 1640/H.R. 879: Medicare Patient Access and Practice Stabilization Act of 2025 - This bill increases certain payment adjustments under the Medicare physician fee schedule for services furnished between April 1, 2025, and January 1, 2026. H.R. 8163: Provider Reimbursement Stability Act, to amend title XVIII of the Social Security Act to ensure stability for provider payments under the Medicare program. H.R. 8622: Medicare Physician Data-driven Performance Payment System Act to amend title XVIII of the Social Security Act to transform the Merit-based Incentive Payment System into the Data-driven Performance Payment System under the Medicare physician fee schedule H.R. 6160: Strengthening Medicare for Patients and Providers Act to modify certain adjustments to payment amounts under the Medicare physician fee schedule S. 1460/H.R. 786: Preserving Patient Access to Accountable Care Act - extends Medicare incentive payments for alternative payment models to 2027, with a new rate of 3.53 percent, to promote continued participation and improve healthcare efficiency. H.R. 2120/S. 1031: ROCR Value Based Program Act - establishes a new payment program for radiation oncology services, focusing on stable payments, quality care, and patient access, while exempting it from budget neutrality adjustments. H.R. 4559: Prompt and Fair Pay Act - to establish payment parity between Medicare Advantage and fee-for-service Medicare, and to establish prompt payment requirements under Medicare Advantage. H.R. 2484: Seniors' Access to Critical Medications Act of 2025 - establishes an exception to the physician self-referral prohibition for certain outpatient drugs under Medicare, mandates a study on drug dispensing practices, and reduces the Medicare improvement fund by $18 million. H.R. 4299: Protecting Patient Access to Cancer and Complex Therapies Act - provide for a rebate by manufacturers for selected drugs and biological products subject to maximum fair price negotiation H.R. 4206/S. 1261: CONNECT for Health Act - expands access to telehealth services under Medicare H.R. 5081/S. 2709: Telehealth Modernization Act - to extend certain telehealth flexibilities under the Medicare program. H.R. 4752/S. 2760: Reducing Hereditary Cancer Act - to provide hereditary cancer genetic testing for individuals with a history of a hereditary cancer gene mutation.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":120202,"prefix":null,"prefix_display":null,"first_name":"KRISTINE","nickname":null,"middle_name":null,"last_name":"RUFENER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141122,"prefix":null,"prefix_display":null,"first_name":"KATIE","nickname":null,"middle_name":null,"last_name":"GIFFORD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154875,"prefix":"ms","prefix_display":"MS.","first_name":"MAUREEN","nickname":null,"middle_name":"ELIZABETH","last_name":"SZEMBORSKI","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"H.R. 6423/S. 864: HELP Copays Act - requires health insurers to count third-party financial assistance toward patients' cost-sharing obligations, including deductibles and copays, for prescription drugs, with changes effective for plan years beginning January 1, 2026. S. 526: PBM Transparency Act - prevents unfair and deceptive acts or practices and the dissemination of false information related to pharmacy benefit management services for prescription drugs H.R. 4191/S. 1784: MAPS Act - requires federal agencies to regularly update a list of essential medicines, assess and report on supply chain risks, map pharmaceutical supply chains, and enhance coordination and cybersecurity to protect public health and national security. H.R. 3955/S.2062: RAPID Reserve Act - establishes a $500 million program to create and maintain domestic reserves of critical drugs and their ingredients, prioritizing domestic manufacturing and supply chain resilience to prevent shortages during public health emergencies. H.R. 8339: Drug Origin Transparency Act to amend the Federal Food, Drug, and Cosmetic Act to enhance drug manufacturing amount information reporting H.R. 5526/S. 1954: Biosimilar Red Tape Elimination Act - streamlines the approval process for biosimilar biological products by automatically deeming them interchangeable with reference products, subject to certain exclusivity protections, and requires updated regulatory guidance to reflect these changes. H.R. 4101: Cancer Drug Parity Act of 2025 - requires group health plans to provide cost-sharing for oral anticancer drugs that is at least as favorable as for provider-administered anticancer medications, with protections against increased patient costs and a mandated GAO study on the law's impact. H.R. 3521/S. 4440: Clinical Trials Modernization Act - Increase clinical trial participation among underrepresented populations by providing grants, permitting certain participant reimbursements, and offering tax exclusions, while ensuring compliance with existing legal protections. S. 705: Innovation in Pediatric Drugs Act of 2025 - amends existing laws to enhance pediatric cancer research, mandates compliance measures, allocates funding for pediatric studies, and sets guidelines for orphan drugs, with specific timelines for implementation and evaluation. H.R. 5509/S. 2903: Safe Step Act - to require a group health plan or health insurance coverage offered in connection with such a plan to provide an exceptions process for any medication step therapy protocol, and for other purposes. H.R. 4425/S. 2287: Palliative Care and Hospice Education and Training Act - expands federal support for workforce development, education, public awareness, and research in palliative and hospice care, with targeted funding and statutory changes to improve care for patients with serious or life-threatening illnesses. H.R. 8839: Lainie Jones Comprehensive Cancer Survivorship Act of 2026 to address the health of cancer survivors.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":120202,"prefix":null,"prefix_display":null,"first_name":"KRISTINE","nickname":null,"middle_name":null,"last_name":"RUFENER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141122,"prefix":null,"prefix_display":null,"first_name":"KATIE","nickname":null,"middle_name":null,"last_name":"GIFFORD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154875,"prefix":"ms","prefix_display":"MS.","first_name":"MAUREEN","nickname":null,"middle_name":"ELIZABETH","last_name":"SZEMBORSKI","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"FY 2026 and FY 2027 Appropriations for the National Institutes of Health (NIH), National Cancer Institute (NCI), the Food & Drug Administration (FDA), the Advanced Research Projects Agency for Health (ARPA-H), the Centers for Disease Control and Prevention (CDC), and the Department of Defense's Congressionally Directed Medical Research Programs (CDMRP).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":120202,"prefix":null,"prefix_display":null,"first_name":"KRISTINE","nickname":null,"middle_name":null,"last_name":"RUFENER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141122,"prefix":null,"prefix_display":null,"first_name":"KATIE","nickname":null,"middle_name":null,"last_name":"GIFFORD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154875,"prefix":"ms","prefix_display":"MS.","first_name":"MAUREEN","nickname":null,"middle_name":"ELIZABETH","last_name":"SZEMBORSKI","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/77618e47-b2ef-4cfa-9896-f031126d61c1/","filing_uuid":"77618e47-b2ef-4cfa-9896-f031126d61c1","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/77618e47-b2ef-4cfa-9896-f031126d61c1/print/","filing_document_content_type":"text/html","income":null,"expenses":"40000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Annie Kennedy","dt_posted":"2026-07-17T11:34:05-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1012 14th NW, Suite 500","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":401106105,"url":"https://lda.gov/api/v1/registrants/401106105/","house_registrant_id":null,"name":"RARE FOUNDATION (FORMERLY KNOWN AS EVERYLIFE FOUNDATION FOR RARE DISEASES)","description":"Nonprofit, nonpartisan organization dedicated to empowering rare disease patient community","address_1":"1012 14th NW, Suite 500","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ANNIE KENNEDY","contact_telephone":"+1 202-697-7273","dt_updated":"2026-10-16T13:50:48.525272-04:00"},"client":{"id":210900,"url":"https://lda.gov/api/v1/clients/210900/","client_id":12,"name":"RARE FOUNDATION (FORMERLY KNOWN AS EVERYLIFE FOUNDATION FOR RARE DISEASES)","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2021-04-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"S. 822, H.R. 1532 - Scientific EXPERT Act of 2025; H.R. 4709 - Newborn Screening Saves Lives Reauthorization Act of 2025; FY 2027 Appropriations; FDA user fee reauthorization; H.R. 7118 - Genomic Answers for Children's Health Act; H.R. 5509, S. 2903 - Safe Step Act; H.R. 1414 - Cameron's Law","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":101949,"prefix":null,"prefix_display":null,"first_name":"JAMIE","nickname":null,"middle_name":null,"last_name":"SULLIVAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":101951,"prefix":null,"prefix_display":null,"first_name":"DYLAN","nickname":null,"middle_name":null,"last_name":"SIMON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/f4b0b8bc-7c0e-4ca9-b780-eaf54b336c73/","filing_uuid":"f4b0b8bc-7c0e-4ca9-b780-eaf54b336c73","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/f4b0b8bc-7c0e-4ca9-b780-eaf54b336c73/print/","filing_document_content_type":"text/html","income":"50000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Katina Pierce","dt_posted":"2026-07-17T13:17:18-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"600 Maryland Avenue SW","registrant_address_2":"Suite 220E","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20024","registrant":{"id":8511,"url":"https://lda.gov/api/v1/registrants/8511/","house_registrant_id":31321,"name":"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.","description":"Consultant firm","address_1":"600 Maryland Avenue SW","address_2":"Suite 220E","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20024","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"KATINA PIERCE","contact_telephone":"+1 202-484-1100","dt_updated":"2026-07-07T12:11:18.019485-04:00"},"client":{"id":209711,"url":"https://lda.gov/api/v1/clients/209711/","client_id":1005383,"name":"HEMATOLOGY ONCOLOGY PHARMACY ASSOCIATION","general_description":"Supports pharmacy practitioners & seeks to promote & advance hematology/oncology pharmacy","client_government_entity":false,"client_self_select":null,"state":"WI","state_display":"Wisconsin","country":"US","country_display":"United States of America","ppb_state":"WI","ppb_state_display":"Wisconsin","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2021-04-01"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"FY27 Labor Health Human Services and Related Agencies","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":98793,"prefix":null,"prefix_display":null,"first_name":"JEREMY","nickname":null,"middle_name":null,"last_name":"SCOTT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69553,"prefix":null,"prefix_display":null,"first_name":"STEFANIE","nickname":null,"middle_name":"CLAUDETTE WINSTON","last_name":"RINEHART","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148303,"prefix":null,"prefix_display":null,"first_name":"KELSI","nickname":null,"middle_name":null,"last_name":"PUTNAM","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Safe Step Act (H.R. 5509 / S. 2903); Cancer Drug Parity Act (H.R. 4101)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":98793,"prefix":null,"prefix_display":null,"first_name":"JEREMY","nickname":null,"middle_name":null,"last_name":"SCOTT","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154339,"prefix":null,"prefix_display":null,"first_name":"STEFANI","nickname":null,"middle_name":null,"last_name":"RINEHART","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/81957379-de14-4ad9-a23f-5bee4044b814/","filing_uuid":"81957379-de14-4ad9-a23f-5bee4044b814","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/81957379-de14-4ad9-a23f-5bee4044b814/print/","filing_document_content_type":"text/html","income":null,"expenses":"460000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Andrew Kenney","dt_posted":"2026-07-17T13:30:21-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"25 Massachusetts Avenue, NW","registrant_address_2":"Suite 500J","registrant_different_address":true,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":300856,"url":"https://lda.gov/api/v1/registrants/300856/","house_registrant_id":37735,"name":"AMERICAN ACADEMY OF NEUROLOGY","description":"Physician trade association","address_1":"25 Massachusetts Avenue, NW","address_2":"Suite 500J","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ANDREW KENNEY","contact_telephone":"+1 760-828-7362","dt_updated":"2026-07-17T12:52:21.513723-04:00"},"client":{"id":180423,"url":"https://lda.gov/api/v1/clients/180423/","client_id":12,"name":"AMERICAN ACADEMY OF NEUROLOGY","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"MN","state_display":"Minnesota","country":"US","country_display":"United States of America","ppb_state":"MN","ppb_state_display":"Minnesota","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2011-04-17"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"CONNECT for Health Act of 2025, H.R. 4206 / S. 1261 Strengthening Medicare for Patients and Providers Act, H.R. 6160 Improving Seniors Timely Access to Care Act, H.R. 3514 / S. 1816 Engagement with CMS regarding National Coverage Analysis (NCA) of monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for a permanent expansion of telehealth in Medicare, including eliminating originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with Medicare physician payment Expressing concerns related to prior authorization","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":107378,"prefix":null,"prefix_display":null,"first_name":"MAX","nickname":null,"middle_name":null,"last_name":"GOLDMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150030,"prefix":null,"prefix_display":null,"first_name":"ANDREW","nickname":null,"middle_name":null,"last_name":"KENNEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Resident Physician Shortage Reduction Act, H.R. 4731 / S. 2439 Conrad State 30 and Physician Access Reauthorization Act, H.R. 1585/S. 709 Resident Education Deferred Interest Act, H.R. 2028 / S. 942 Safe Step Act, H.R. 5509 / S. 2903 - Improving Seniors Timely Access to Care Act, H.R. 3514 / S. 1816 H-1Bs for the Physicians and Healthcare Workforce Act, H.R. 7961 Urging support for and the bolstering of the neurology workforce Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Medical research funding related to NIH including the BRAIN Initiative, NINDS, ARPA-H, NIA - Issues related to animal testing in medical research Seeking exemption for physicians and other health professionals from the new $100,000 H-1B fee Requesting national interest exceptions and expedited processing for physicians and medical trainees for entering and maintaining legal residency in the United States","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":107378,"prefix":null,"prefix_display":null,"first_name":"MAX","nickname":null,"middle_name":null,"last_name":"GOLDMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150030,"prefix":null,"prefix_display":null,"first_name":"ANDREW","nickname":null,"middle_name":null,"last_name":"KENNEY","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":201,"name":"Homeland Security, Dept of (DHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"},{"id":39,"name":"State, Dept of (DOS)"},{"id":42,"name":"Veterans Affairs, Dept of (VA)"}]},{"general_issue_code":"VET","general_issue_code_display":"Veterans","description":"Support for increased funding for the VA Neurology Centers of Excellence, which include centers dedicated to Epilepsy, Multiple sclerosis, Headache, and Parkinsons disease. Support for the VA Medical and Prosthetic Research Program VA teleneurology and patient access to telehealth - VA neurology workforce issues","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":107378,"prefix":null,"prefix_display":null,"first_name":"MAX","nickname":null,"middle_name":null,"last_name":"GOLDMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150030,"prefix":null,"prefix_display":null,"first_name":"ANDREW","nickname":null,"middle_name":null,"last_name":"KENNEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":42,"name":"Veterans Affairs, Dept of (VA)"}]},{"general_issue_code":"INS","general_issue_code_display":"Insurance","description":"-Safe Step Act, H.R. 5509 / S. 2903 -Issues related to step therapy reform -Issues related to telehealth access -Issues related to utilization management reform","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":107378,"prefix":null,"prefix_display":null,"first_name":"MAX","nickname":null,"middle_name":null,"last_name":"GOLDMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150030,"prefix":null,"prefix_display":null,"first_name":"ANDREW","nickname":null,"middle_name":null,"last_name":"KENNEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Medical research funding related to NIH including the BRAIN Initiative, NINDS, ARPA-H, NIA Support for increased funding for the VA Neurology Centers of Excellence, which include centers dedicated to Epilepsy, Multiple sclerosis, Headache, and Parkinsons disease.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":107378,"prefix":null,"prefix_display":null,"first_name":"MAX","nickname":null,"middle_name":null,"last_name":"GOLDMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150030,"prefix":null,"prefix_display":null,"first_name":"ANDREW","nickname":null,"middle_name":null,"last_name":"KENNEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/81957379-de14-4ad9-a23f-5bee4044b814/","filing_uuid":"81957379-de14-4ad9-a23f-5bee4044b814","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/81957379-de14-4ad9-a23f-5bee4044b814/print/","filing_document_content_type":"text/html","income":null,"expenses":"460000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Andrew Kenney","dt_posted":"2026-07-17T13:30:21-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"25 Massachusetts Avenue, NW","registrant_address_2":"Suite 500J","registrant_different_address":true,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":300856,"url":"https://lda.gov/api/v1/registrants/300856/","house_registrant_id":37735,"name":"AMERICAN ACADEMY OF NEUROLOGY","description":"Physician trade association","address_1":"25 Massachusetts Avenue, NW","address_2":"Suite 500J","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ANDREW KENNEY","contact_telephone":"+1 760-828-7362","dt_updated":"2026-07-17T12:52:21.513723-04:00"},"client":{"id":180423,"url":"https://lda.gov/api/v1/clients/180423/","client_id":12,"name":"AMERICAN ACADEMY OF NEUROLOGY","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"MN","state_display":"Minnesota","country":"US","country_display":"United States of America","ppb_state":"MN","ppb_state_display":"Minnesota","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2011-04-17"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"CONNECT for Health Act of 2025, H.R. 4206 / S. 1261 Strengthening Medicare for Patients and Providers Act, H.R. 6160 Improving Seniors Timely Access to Care Act, H.R. 3514 / S. 1816 Engagement with CMS regarding National Coverage Analysis (NCA) of monoclonal antibodies directed at amyloid beta plaque for the treatment of Alzheimers Disease. Support for a permanent expansion of telehealth in Medicare, including eliminating originating site and geographic restrictions. Support for policies to address prescription drug costs, including supporting direct negotiation in Medicare, improving drug pricing transparency, and capping beneficiary out-of-pocket costs in Medicare Part D. Expressing concerns with Medicare physician payment Expressing concerns related to prior authorization","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":107378,"prefix":null,"prefix_display":null,"first_name":"MAX","nickname":null,"middle_name":null,"last_name":"GOLDMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150030,"prefix":null,"prefix_display":null,"first_name":"ANDREW","nickname":null,"middle_name":null,"last_name":"KENNEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Resident Physician Shortage Reduction Act, H.R. 4731 / S. 2439 Conrad State 30 and Physician Access Reauthorization Act, H.R. 1585/S. 709 Resident Education Deferred Interest Act, H.R. 2028 / S. 942 Safe Step Act, H.R. 5509 / S. 2903 - Improving Seniors Timely Access to Care Act, H.R. 3514 / S. 1816 H-1Bs for the Physicians and Healthcare Workforce Act, H.R. 7961 Urging support for and the bolstering of the neurology workforce Urging reforms to proposed surprise billing regulations to align with congressional intent for payment disputes. Medical research funding related to NIH including the BRAIN Initiative, NINDS, ARPA-H, NIA - Issues related to animal testing in medical research Seeking exemption for physicians and other health professionals from the new $100,000 H-1B fee Requesting national interest exceptions and expedited processing for physicians and medical trainees for entering and maintaining legal residency in the United States","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":107378,"prefix":null,"prefix_display":null,"first_name":"MAX","nickname":null,"middle_name":null,"last_name":"GOLDMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150030,"prefix":null,"prefix_display":null,"first_name":"ANDREW","nickname":null,"middle_name":null,"last_name":"KENNEY","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":201,"name":"Homeland Security, Dept of (DHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"},{"id":39,"name":"State, Dept of (DOS)"},{"id":42,"name":"Veterans Affairs, Dept of (VA)"}]},{"general_issue_code":"VET","general_issue_code_display":"Veterans","description":"Support for increased funding for the VA Neurology Centers of Excellence, which include centers dedicated to Epilepsy, Multiple sclerosis, Headache, and Parkinsons disease. Support for the VA Medical and Prosthetic Research Program VA teleneurology and patient access to telehealth - VA neurology workforce issues","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":107378,"prefix":null,"prefix_display":null,"first_name":"MAX","nickname":null,"middle_name":null,"last_name":"GOLDMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150030,"prefix":null,"prefix_display":null,"first_name":"ANDREW","nickname":null,"middle_name":null,"last_name":"KENNEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":42,"name":"Veterans Affairs, Dept of (VA)"}]},{"general_issue_code":"INS","general_issue_code_display":"Insurance","description":"-Safe Step Act, H.R. 5509 / S. 2903 -Issues related to step therapy reform -Issues related to telehealth access -Issues related to utilization management reform","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":107378,"prefix":null,"prefix_display":null,"first_name":"MAX","nickname":null,"middle_name":null,"last_name":"GOLDMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150030,"prefix":null,"prefix_display":null,"first_name":"ANDREW","nickname":null,"middle_name":null,"last_name":"KENNEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Medical research funding related to NIH including the BRAIN Initiative, NINDS, ARPA-H, NIA Support for increased funding for the VA Neurology Centers of Excellence, which include centers dedicated to Epilepsy, Multiple sclerosis, Headache, and Parkinsons disease.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":107378,"prefix":null,"prefix_display":null,"first_name":"MAX","nickname":null,"middle_name":null,"last_name":"GOLDMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150030,"prefix":null,"prefix_display":null,"first_name":"ANDREW","nickname":null,"middle_name":null,"last_name":"KENNEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}]}